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Abstract: 
Astrocytes posses a wide range of functions within the brain. In response to ischemic 
conditions they swell due to increased uptake of osmolytes and they are mainly responsible 
for cytotoxic edema formation. However, they are also able to regulate their volume by 
releasing osmolytes together with water via the process of regulatory volume decrease 
(RVD). The Aquaporin 4 (AQP4) channel and Transient receptor potential vanilloid 4 
(TRPV4) channel are suspected to be strongly involved in these processes of astrocytic 
volume regulation. The goal of the present diploma thesis was to clarify the role of both 
channels in astrocytic swelling in situ.  
For our experiments we used a subpopulation of green fluorescent protein-labelled 
astrocytes from AQP4-deficient (AQP4-/-), TRPV4-deficient (TRPV4-/-) and control (Ctrl) 
mice. Cell volume alterations were induced in acute brain slices by hypoosmotic stress or by 
oxygen-glucose deprivation (OGD). Data were quantified using fluorescence intensity-based 
approach in the whole cells and in astrocytic endfeet. 
Our results indicate, that there is no difference in astrocytic swelling or cell volume 
recovery between astrocytes from AQP4-/-, TRPV4-/- and control mice when exposed to 
hypoosmotic stress. On the contrary, volume changes induced by OGD varied significantly 
between the experimental groups. Astrocytes from AQP4-/- mice showed only a weak 
increase in their volume in response to OGD, while they were unable to recover their volume 
when returned to normal arteficial cerebrospinal fluid (aCSF). Interestingly, the swelling of 
astrocytes from TRPV4-/- mice was comparable to that observed in controls. However, they 
were unable to recover their volume when returned to normal aCSF as observed in astrocytes 
from AQP4-/- mice. 
 
Key words: Aquaporin 4, ischemia, Transient receptor potential vanilloid 4, water 
transport
Abstrakt: 
Astrocyty mají v mozku celou řadu funkcí. V  ischemických podmínkách zvětšují 
svůj objem v důsledku zvýšeného příjmu osmolytů a jsou tedy z velké části zodpovědné za 
rozvoj cytotoxického edému mozku. Jsou ale také schopné regulovat svůj objem 
uvolňováním osmolytů společně s vodou. Tento proces je nazýván regulované snižování 
buněčného objemu (RVD). Za kanály, které se regulace objemu astrocytů významně účastní, 
jsou považovány Aquaporin 4 (AQP4) a Transient receptor potential vanilloid 4 (TRPV4). 
Cílem této diplomové práce bylo objasnit úlohu obou těchto kanálů při objemových změnách 
astrocytů  in situ. 
Experimenty byly prováděny na populaci astrocytů, které byly značené zeleným 
flourescenčním proteinem a pocházely z AQP4-deficientních (AQP4-/-), 
TRPV4-deficientních (TRPV4-/-) a kontrolních (Ctrl) myší. Objemové změny byly vyvolány 
v mozkových řezech hypoosmotickým stresem a kyslíkovo-glukózovou deprivací (OGD). 
Data byla analyzována na základě změn intensity fluorescence v celých buňkách a 
v astrocytálních patkách. 
Při aplikaci hypoosmotického stresu jsme mezi našimi experimentálními skupinami 
nenašli žádné rozdíly ve zvětšování objemu buněk nebo následném snižování buněčného 
objemu. Naopak objemové změny vyvolané aplikací OGD se mezi jednotlivými skupinami 
významně lišily. Astrocyty z AQP4-/- myší zvyšovaly svůj objem v reakci na OGD pouze 
mírně a po návratu do arteficiální cerebrospinální tekutiny (aCSF) nebyly schopné obnovit 
svůj původní objem. Astrocyty z TRPV4-/- myší měnily svůj objem stejným způsobem jako 
kontroly. Po návratu do aCSF nebyly nicméně schopné obnovit svůj původní objem, stejně 
jako buňky z AQP4-/- myší. 
 
Klíčová slova: Aquaporin 4, ischemie, Transient receptor potential vanilloid 4, 
transport vody  
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Abbreviations 
 
2D – two dimensional 
3D – three dimensional 
AA – Arachidonic acid 
aCSF – Arteficial cerebrospinal fluid 
ALDH1L1 – Aldehyde dehydrogenase 1 family, member L1 
AQP4 – Aquaporin 4 
AQP4e – Isoforme of Aquaporin 4 
AQP4-/- – AQP4-deficient mice 
α-Syn – α-Syntrophin 
BBB – Blood brain barrier 
BDNF – Brain-derived neurotrophic factor 
BK – Big potassium channel 
Ca2+ – Calcium cation 
[Ca2+]i – Intracellular concentration of calcium cations 
CaCl2 – Calcium chloride 
Calcein-AM – Calcein-acethomethyl 
CHIP28 – Integral membrane protein of red blood cells, later renamed  Aquaporin 
ClC-2 – Chloride channels type 2S 
CNS – Central nervous system 
Ctrl – Control 
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Cx30, Cx43 – Connexin 30, Connexin 43 
EAAT – Excitatory amino acid transporter 
ECS – Extracellular space 
EETs – Eicosanoid metabolites 
EGFP – Enhanced green fluorescent protein 
FI – Fluorescence intensity 
Fig. – Figure 
GFAP – Glial fibrillary acidic protein 
HT – High temperature (32°C) 
Hypo – Hypotonic solution 
IgG – Immunoglobulin G 
K+ – Potassium cation 
KCl – Potassium chloride 
Kir4.1 – Inwardly rectifying potassium channel 4.1 
M1, M23, Mz – Isoformes of Aquaporin 4 
MCAO – Middle cerebral artery occlusion 
MgCl2 – Magnesium chloride 
Na+ – Sodium cation  
[Na+]i – Intracellular concentration of sodium cations 
Na2HPO4 – Sodium phosphate dibasic 
NaHCO3 – Sodium bicarbonate 
NG2 – Nerve/glial antigen 2 
NGF – Nerve growth factor 
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NKCC1 – Na+/K+/Cl--cotransporter type 1 
NMDG-Cl – N-methyl-D-glucamine chloride 
NMDA – N-methyl-D-aspartate 
NMO – Neuromyelitis optica 
NVC – Neurovascular coupling 
OAP – Orthogonal array of particles 
OGD – Oxygen glucose deprivation 
OPC – Oligodendrocyte progenitor cell 
PIP2 – Phosphatidylinositol-4,5-bisphosphate 
PLA2 – Phospholipase A2 
PNS – Periferal nervous system 
RT – Room temperature (23°C) 
RVD – Regulatory volume decrease 
SEM – Standard error of the mean 
SUR1 – Sulfonylurea receptor 1 
Tab. – Table 
TRP – Transient receptor potential 
TRPM4 – Transient receptor potential melastatin 4 
TRPV4 – Transient receptor potential vanilloid 4 
TRPV4-/- – TRPV4-deficient mice 
VRAC/LRRC8 – Volume regulated anion channels 
Wash – Washout 
Z-stack – Set of focal images 
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1 Introduction  
 
Ischemic brain injury is a leading cause of death and adult disability worldwide, 
moreover it is also well described in infants as a cause of neurological morbidity. Ischemic 
brain injury results from tromboembolic occlusion of a major cerebral artery or its branches, 
from a traumatic brain injury, cardiac arrest or even tumor growth/formation. So far, there is 
no reliable treatment for patients suffering from ischemic brain injury, therefore, numerous 
research projects are focused on elucidating the pathological mechanisms and identifying 
new drug targets in order to improve patient‘s outcome. Cerebral ischemia and trauma, as 
well as brain tumors, are accompanied by the development of brain edema, which represents 
a severe complication of above listed CNS disorders. 
For decades, the researchers were mostly interested in rescuing damaged neurons, for 
example by targeting neuronal receptors, such as N-methyl-D-aspartate receptors. Currently, 
their attention turned towards glial cells, namely astrocytes, as these cells provide numerous 
essential functions, such as maintenance of ionic and neurostransmitter homeostasis, water 
transport, pH regulation, energy supply for neurons and even local blood flow regulation 
(Sofroniew and Vinters, 2010). 
Under pathological conditions astrocytes markedly take up ions and neurotransmitters 
together with water, which results in an increase in astrocytic volume and therefore, these 
cells represent the main contribution to the development of brain edema. On the other hand, 
astrocytes are able to regulate their swelling by releasing osmotically active substances 
together with water, in the process termed regulatory volume decrease (RVD). 
The aquaporin 4 (AQP4) channel and transient receptor potential vanilloid 4 (TRPV4) 
channel promptly respond to changed osmotic conditions within the brain tissue. Both AQP4 
and TRPV4 channels are expressed on astrocyte membranes, and the recent findings suggest 
that these channels might represent possible targets for treating post-ischemic or 
post-traumatic edema formation. In addition, the involvement of AQP4 and TRPV4 channels 
in RVD was proposed in several studies (Benfenati et al., 2011; Jo et al., 2015; Iuso and 
Križaj, 2016). 
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The goal of the present diploma theses is to clarify the role of both channels in 
astrocytes in situ and compare the results with already known facts about their role in the cell 
volume regulation in cultured cells. 
 
2 Ischemic brain injury 
 
In general, ischemia is a cellular depletion of energy substrates (oxygen and glucose 
mainly), which leads to ionic-pump failure and to the disruption of ionic homeostasis 
(Schuier and Hossmann, 1980; Rosenberg, 1999). The lack of oxygen activates anaerobic 
metabolism pathways and lactate builds up, which decreases cellular pH. That - together with 
energy depletion - disturbs cellular osmoregulation, which is highly dependent on Na+/K+ 
ATPase and proton-dependent cotransport systems, and leads to the massive influx of water 
into the cells. These processes result in brain edema formation (Klatzo, 1987; Rosenberg, 
1999).  
Brain edema is defined as an abnormal water accumulation within the brain 
parenchyma, which causes an enlargement of the affected tissue and an increase in 
intracranial pressure (Klatzo, 1987, 1994). Besides ischemic injury, brain edema accompanies 
a wide range of brain and body pathologies, such as traumatic brain injuries, meningitis or 
hepatic encephalopathy (Ransom and Blank, 1975; Klatzo, 1987). It can be localized, thus 
affecting only a part of the brain, or generalized and spread through the whole brain 
parenchyma (Ransom and Blank, 1975). In the case of ischemia, the brain water content is 
already increased within an hour after the ischemic attack. However, it continuously increases 
for about 24 hours, when it reaches its peak, and then it starts to decline slowly (Hatashita, 
Hoff and Salamat, 1988). Under physiological conditions brain tissue is hyperosmolar when 
compared to blood plasma, while during ischemic brain injury the osmolarity differences rise 
significantly, which leads to massive water influx to the brain parenchyma (Hatashita, Hoff  
and Salamat, 1988).  
Historically, the concept of two brain edema types was established. The vasogenic 
type, which is characterized by a blood-brain barrier (BBB) breakdown and an increase in its 
permeability. During this process water enters the brain an accumulates in extracellular space. 
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That causes its enlargement and results in compression of the cells in the affected area. The 
second type is cytotoxic edema and in contrast to the vasogenic type, it is characterized by 
water accumulation within the cellular elements of the brain parenchyma and leads to the 
shrinkage of the extracellular space (Ransom and Blank, 1975; Klatzo, 1994). Evidence 
showed that it is often the brain edema, which causes the fatal outcome of brain damage and 
that it is both, the cytotoxic and the vasogenic type of edema that play a key role in the 
severity of ischemic brain damage. 
2.1 Cellular death 
The process of hypoxic-ischemic injury is accompanied by an inflammatory and 
neurodegenerative response of the brain tissue, which leads to the death of brain cellular 
elements (Northington et al., 2001). Ischemia-induced cell death was described mostly on 
neuronal cells, where the neurodegenerative processes following ischemic injury occurr 
mainly by programmed cell death (apoptosis), necrosis, autophagy and excitotoxicity (or 
combination of those) (Linnik et al., 1993; Cheng et al., 1998; reviewed in Northington, 
Chavez-Valdez and Martin, 2011). The particular mechanisms of cell death - described in 
neonatal ischemic injury - are time distinguished. At the early phase, the necrosis takes place, 
followed by a delayed phase of apoptosis and inflammation with a secondary phase of 
necrosis (Northington et al., 2001; Carloni et al., 2007). It is also suggested that the necrotic 
death of a certain group of neurons can result in the death of other connected cells 
(Northington et al., 2001).  
The synapses between neurons enable cell communication, but can also represent the 
trigger for damaging processes, in general called the excitotoxicity. In a healthy brain, the 
excitatory synaptic transmission is mediated mostly by glutamate. In case of ischemia (or 
another brain damage), the glutamate release can cause excessive neuronal activation, which 
leads to cytotoxic cellular swelling, degeneration of cell compartments and to the death and 
phagocytosis of the cells (Olney, Ho and Rhee, 1971; Choi, 1988). During ischemia, the 
glutamate is extensively released from synaptic terminals in response to excessive 
stimulation. It is released into the extracellular space, from where it is cleared by astrocytes. 
The pool of glutamate in ischemic glia is increased by about 60 %, compared to the 
physiological levels (Torp et al., 1991). However, glutamate does not remain in astrocytes. 
Under ischemic conditions, the glutamate transporters on astrocytic membranes reverse their 
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function and glutamate is released back into the extracellular space, where it further affects 
neuronal functions (Rossi, Oshima and Attwell, 2000).  
Glutamate opens ion channels in neuronal membranes and allows sodium cations 
(Na+) to enter the cells. In healthy brain the Na+ is removed from the cells by Na+/K+ 
ATPase, while during ischemia, when the neuronal depolarization is repetitive and 
continuous, the intracellular concentration of sodium [Na+]i increases above physiological 
levels and is followed by a massive influx of water, which leads to cellular swelling (Olney et 
al., 1986). In ischemic brain, extracellular glutamate causes long-term depolarization of 
neurons that interrupts local cerebral functions and results in an enlargement of infarct lesion 
(Mies, Iijima and Hossmann, 1993; Dijkhuizen et al., 1999). These changes are more 
prominent in the lesion core, where the depolarization is irreversible. On the contrary, on the 
border zones of the lesion (in penumbra) the changes caused by depolarization, as well as 
depolarization itself, can be transient (Dijkhuizen et al., 1999). The cellular swelling and 
damage mediated by Na+ is strengthened by an increased influx of calcium cations (Ca2+) 
(Berdichevsky et al., 1983) and the same effect can also be caused by glutamate analogs, such 
as aspartic acid or kainate, and increased levels of extracellular potassium cations (K+) 
(Olney, Ho and Rhee, 1971; Berdichevsky et al., 1983; Busch et al., 1996). 
2.2 Models of Ischemia 
Ischemia is intensively studied using in vitro and in vivo models. Each model has its 
advantages and shortcomings, but altogether they are useful tools for studying and mimicking 
human pathologies. In vitro models (cell cultures) hold many possibilities, because they can 
vary in cell type and in the animal species, they are prepared from and they are usually used 
for studying molecular events during ischemia. Primary cultures are most often isolated from 
mice or rats, but can also originate from bovine brain or primates. Another option for in vitro 
models of ischemia are immortalized cell lines originating from variable organisms and cell 
types. These models can include single cell type (monoculture) or more cell types that are 
co-cultured together in the same conditions (reviewed in Tornabene and Brodin, 2016). Often 
used in vitro treatment is oxygen-glucose deprivation (OGD), which is employed in order to 
mimic the disruption of oxygen and nutrients supply to the brain. In OGD, the cells are 
cultivated in glucose-free media in an atmosphere of zero or low (5 – 7 %) oxygen. This 
exposure can last from about 15 minutes to more than a day. The OGD can be performed also 
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on acute brain slices, which more likely resemble pathophysiology of living animals (Tasca, 
Dal-Cim and Cimarosti, 2015). 
Animal models of ischemia relatively closely simulate human pathology, although in 
human brain the ischemic injury has different manifestation, localization, cause and outcome 
in every patient. These models can be provided on genetically modified animals, and thus 
help researchers to understand the roles of different proteins and molecules in a proper 
context in pathological situations in vivo.  
Figure 1: Rodent models of ischemia. 1. Brief occlusion of the bilateral common carotid arteries 
combined with either vertebral artery coagulation (four-vessel occlusion, ➀+➁); 2. Brief occlusion 
of the bilateral common carotid arteries with systemic hypotension (two-vessel occlusiov, ➀
+systemic hypotension); 3. Brief occlusion of one middle cerebral artery (MCAO, ➂); 4. Occlusion 
of unilateral femoral artery or the infrarenal abdominal aorta (remote ischemia, ➃ or ➄). Taken 
from: Stelter et al., 2014 
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In vivo, we distinguish two types of cerebral ischemia, focal or global. In focal 
ischemia, the blood flow is reduced only in a distinct region of the brain, whereas in the 
global ischemia the blood flow is reduced in the entire brain (reviewed in Bacigaluppi, Comi 
and Hermann, 2010). As mentioned above, most of the ischemic injuries result from 
occlusion of a major brain vessel or its branches (mostly of the middle cerebral artery, 
Fig. 1). For this reason, the middle cerebral artery occlusion (MCAO) model was developed 
(reviewed in Fluri, Schuhmann and Kleinschnitz, 2015). It is a highly reproducible method of 
standardized experimental stroke, which is usually performed on mice or rats, but using 
larger animals, such as primates, is also possible (reviewed in Durukan and Tatlisumak, 
2007). MCAO is a typical model of focal ischemia. The occlusion can be transient, and allow 
reperfusion, or permanent (Kaneko, Nakamura and Ogawa, 1985; reviewed in Liu and 
McCullough, 2011). In the transient MCAO, the vessel is blocked, so it would not allow any 
blood flow, for a defined period on time (hours mostly) and then the blockage is removed and 
the nervous tissue is reperfused. In the permanent MCAO models, the vessel remains 
occluded through the entire experiment, without the reperfusion phase (reviewed in Liu and 
McCullough, 2011 and Woodruff et al., 2011).  
Another possible approach is using global models of ischemia. In the past, these 
models were suspected to have much lesser clinical significance, compared to the focal 
approaches. However, currently the global models of ischemia are considered to be of great 
clinical relevance, especially to pathologies, such as cardiac arrest or asphyxia (McBean and 
Kelly, 1998). In experimental animals, global ischemia is usually induced by multiple vessel 
occlusion, typically both carotids (two-vessel occlusion, Fig. 1) or carotids and vertebral 
arteries (four-vessel occlusion, Fig. 1). Complete global ischemia can be achieved by 
neck-cuff, cardiac arrest or – without the possibility of reperfusion – by decapitation 
(reviewed in Woodruff et al., 2011). 
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3 Glial cells 
 
Glial cells are also called neuroglia or simply glia. During history, glial cells were 
described as ‚helper‘ cells for the neurons, with just basic functions and no role in neural 
system development or diseases. However, with the progress of technology and science, the 
view on glial cells changed. Today, glial cells comprise a population of non-neuronal cells in 
the central and peripheral nervous system (CNS and PNS) that occupy about a half of the 
brain / spinal cord volume and play a crucial role in CNS development, its normal, healthy 
functioning and in pathologies. The term ‚glial cells‘ describes a wide category, which 
Figure 2: Glial cells in an adult brain. Astrocytes (blue) envelope synapses and make close 
contacts with blood vessels. Microglia (red) constantly screen brain tissue and answer to 
microenvironment changes by their activation and changes of morphology. Oligodendrocytes 
(gray) create myelin sheats around axons and accelerate neuronal communication. Taken from: 
Jeuregui-Huerta et al., 2010
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contains several cell types with different and very specialized functions. In the PNS the main 
cell types are Schwann cells, which form myelin sheaths around axons, and amphicytes, 
small cells with short processes surrounding neuronal soma. In the CNS the situation of glial 
cells is more complicated because in CNS more types of glia can be found (reviewed in 
Jessen, 2004; Fig. 2).  
3.1 Oligodendrocytes 
Oligodendrocytes are myelinating cells of the CNS and make about 5 – 8 % of the 
glial population in a healthy brain. Oligodendrocytes differentiate from oligodendrocyte 
progenitor cells (OPCs). These arise from neural stem cells in specialized domains in a 
response to local factors, such as Olig proteins, and migrate to reach all parts of CNS, where 
these progenitors differentiate into mature oligodendrocytes (Yang, Lewis and Miller, 2011). 
Each oligodendrocyte envelopes a few axons in several layers of myelin coat. This increases 
the speed of axonal conductance as well as the efficiency of neural transmission. The number 
of myelin coats created by single oligodendrocyte is regulated by individual axons and their 
activity (Almeida et al., 2011; Mensch et al., 2015).  
Thanks to the close contacts between oligodendrocytes and neurons a question arose, 
whether the oligodendrocytes couple with neurons or any other cell type. The coupling is 
quite common between CNS glial cells (especially astrocytes). Formation of gap junctions 
was proven between astrocytes and oligodendrocytes, which express three different types of 
connexin proteins. These are able to assemble into heterodimers with astrocytic connexins 
(Magnotti, Goodenough and Paul, 2011). Furthermore, the astrocyte – oligodendrocyte gap 
junctions are required for proper axonal myelination and their loss leads to myelin 
vacuolization (Tress et al., 2012). Also, the oligodendrocytes in white matter are coupled and 
form a functional network. Some results even show, that the coupling between two 
oligodendrocytes is stronger than that between oligodendrocytes and astrocytes (Maglione et 
al., 2010).  
3.2 Microglia 
Microglia are small glial cells with a large number of short branching processes. They 
are CNS macrophages with a wide range of functions in development, neuroinflammation, 
disease and brain injury. They comprise about 10 % of the glial population. Microglial 
12 
 
progenitors can be detected in early embryonic development and originate from the first wave 
of hemopoietic cells from a yolk sac (Alliot, Godin and Pessac, 1999; Ginhoux et al., 2010). 
During development microglia at first accumulate in the white matter and they migrate to the 
gray matter in the later postnatal phases. In the ‚white matter phase‘, their morphology is 
amoeboid or they have a few thick processes (Ueno et al., 2013). They also produce 
neurotrophic factors - proteins that regulate neuronal functions and survival. Microglia were 
shown to constitutively produce brain-derived neurotrophic factor (BDNF) and when 
stimulated, they also produce nerve growth factor (NGF) (Nakajima et al., 2001; Ueno et al., 
2013). Via production of BDNF and NGF (and other factors), microglia play a key role in the 
developmental and adult brain plasticity. Recent studies have suggested, that microglia 
participate also in the processes of learning and memory by learning-induced remodeling of 
excitatory synapses (Pascual et al., 2012; Parkhurst et al., 2014). 
Microglia are usually viewed as CNS resident macrophages. They survey their 
surrounding by moving their processes. Such motility of microglial processes is due to via 
rearrangement of actin filaments (Nimmerjahn, Kirchhoff and Helmchen, 2005). In response 
to pathological stimulation, microglia change their phenotype and transform from so-called 
ramified or resting cells (small cells with short processes) into an amoeboid phenotype. The 
amoeboid cells show enhanced motility and express sets of membrane receptors, which 
enable them to migrate to the sites of inflammation and infiltrate it soon after the brain injury. 
The migration is driven by proteins of complement and their receptors on the microglial 
surface (Nolte et al., 1996). These cells are capable of phagocytosis and production of 
pro-inflammatory cytokines (Parakalan et al., 2012) and also a production of glia-promoting 
factors - proteins, that stimulate astrocytes and support their transformation into a reactive 
state (Giulian and Baker, 1985). 
3.3 NG2 glia 
NG2 glia are a cell population, which is committed to the OPCs and also termed 
polydendrocytes. They exist in the white as well as grey matter, and they were found in 
developmental phases as well as in adulthood. They express transmembrane chondroitin 
sulfate proteoglycan named nerve/glial antigen 2 (NG2). NG2 glia are highly reactive cells, 
that play an important role in nerve injury (Dawson et al., 2003). 
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NG2 cells are able to undergo dramatic changes and they proliferate and develop into 
oligodendrocytes and astrocytes. In vitro, these cells are capable of differentiating even into 
neurons, depending on the conditions (Kondo and Raff, 2000; Honsa et al., 2016). In vivo, 
the results are rather contradictory. It was demonstrated that NG2 glia are able to differentiate 
into oligodendrocytes during the whole life span (Kang et al., 2010; Huang et al., 2014), 
while their differentiation into astrocytes in vivo was confirmed during development in 
prenatal stages (Huang et al., 2014), and after ischemia, when NG2 cells increase their 
expression of glial fibrillary acidic protein (GFAP – astrocyte marker) and their phenotype 
change towards reactive astrocytes (Honsa et al., 2016). 
3.4 Astrocytes 
Astrocytes (or astroglia) represent the largest population of glial cells within the brain 
and can be found in the entire brain parenchyma. The number of astrocytes varies between 
the species, as well as the ratio of astrocytes to neurons, which also differs among individual 
regions of the brain. In mammalian brains, astrocytes outnumber neurons for example in 
cortical regions, but they are outnumbered by neurons in the cerebellum (Herculano-Houzel, 
2014).  
Astrocytes display a specific and quite complicated morphology. On the basis of their 
morphology and distribution in CNS distinct types of astrocytes were identified (Miller and 
Raff, 1984). Fibrous astrocytes are localized mainly in the white matter. They have many 
long fiber-like processes which spread quite regularly. Contrarily, the protoplasmic astrocytes 
are localized in gray matter and typically posses fewer processes that are organized 
irregularly (Miller and Raff, 1984). Electron microscopic analyses showed that both types 
vary also in their contacts with neuronal cells. Whereas the processes of protoplasmic 
astrocytes surround synapses more often, the fibrous astrocytes contact nodes of Ranvier 
(Sofroniew and Vinters, 2010). In human and hominid brains, however, other specialized 
types were described: interlaminar and varicose projection astrocytes (Oberheim et al., 2010). 
All four types identified in the human brain have their specific morphology. The varicose 
projection astrocytes have long processes with varicosities (spaced every 10 µm) which are 
straight with a small number of branches. The function of these branches is not known 
(Oberheim et al., 2010). A relatively small number of these cells was found in the layers 5 
and 6 of the cortex. Primate-specific interlaminar astrocytes localize strictly in the cortical 
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layer 1. They have an oblong soma and processes that extend to both, the pial surface and 
deeper layers of the brain (Oberheim et al., 2010). 
On a molecular basis, all astrocytes can be identified immunohistochemically by 
using antibodies against specific protein markers. The most frequently used is the glial 
fibrillary acidic protein (GFAP). It is an important structural protein and component of 
intermediate filaments in astrocytes, together with vimentin and nestin. GFAP is expressed in 
different isoforms and their localization varies in the brain regions and they also have distinct 
subcellular localization (Thomsen et al., 2013). Recently, aldehyde dehydrogenase 1 family, 
member L1 (ALDH1L1) was identified as the new astroglial marker (Cahoy et al., 2008). It 
is a folate enzyme that converts 10-formyltetrahydrofolate to tetrahydrofolate, playing an 
important role in many reactions like de novo nucleotide biosynthesis and the regeneration of 
methionine, thus having a major impact on cell division and growth (Krupenko, 2009). 
3.4.1 Astrocyte functions 
Astrocytes posses a wide range of functions, which differ in developing and in the 
adult brain. It was demonstrated that in developing brain astrocytes affect neuronal migration 
and formation of functional synapses. In adult brain they provide trophic support for neurons 
– they produce glycogen and transport lactate to neurons. They also respond to the neuronal 
excitation and regulate cerebral blood flow. Moreover, astrocytes play a key role in brain 
damage and glial scar formation (reviewed in Sofroniew and Vinters, 2010). 
All types of astrocytes have one specificity in common: they create gap junctions and 
thus are connected into a complicated network, which is termed syncitium (Anders et al., 
2014; Le et al., 2014). Astrocyte gap junctions are formed by connexin 43 (Cx43) and 
connexin 30 (Cx30) proteins, which assemble hexameric hemichannels in membranes. Two 
hemichannels build a gap junction and connect the cytosols of two astrocytes (Unger et al., 
1999). This connection allows astrocytes to carry out specialized functions, which are linked 
to their main role in an adult brain – maintenance of homeostasis. As was mentioned above, 
astrocytes create gap junctions also with other cell types, such as oligodendrocytes, and thus 
form one extensive panglial network through the whole brain (Liu et al., 2002; Magnotti, 
Goodenough and Paul, 2011; Tress et al., 2012). 
Astrocytes maintain ionic and neurotransmitter homeostasis in CNS, especially 
homeostasis of glutamate. Glutamate is the main excitatory neurotransmitter in the brain, 
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with a wide range of functions, and its extracellular levels rise only in a response to neuronal 
activation. Glutamate interacts with a set of membrane receptors, that are both – ionic 
channels and G-protein coupled receptors. Long-term exposure to glutamate causes 
disruption of membrane potential in neurons and leads to their damage and cellular death 
(Choi, 1988). Astrocytic processes, which envelope synapses, express glutamate 
transporters – such as excitatory amino acid transporters (EAATs) - in abundance, and thus 
are able to remove glutamate rapidly from synapses and stop the signal transmission 
(Armbruster, Hanson and Dulla, 2016). 
3.4.2 Cerebral blood flow regulation  
One of the essential astrocytic functions in CNS is K+ buffering.  In the brain, K+ is 
released from neurons following their increased activity, namely generation of action 
potentials. Astrocytes transport K+ from extracellular space via specific channels into 
intracellular space and through gap junctions to the other parts of brain parenchyma, where 
the concentration of K+ is low. Thanks to this redistribution an increased activity in any part 
of the brain does not lead to a disruption of brain homeostasis and to neuronal damage 
(Witthoft, Filosa and Karniadakis, 2013). K+ is also released from astrocytic endfeet on the 
glia-vascular surface and influence the permeability of BBB and cerebral blood flow in 
connection to increased neuronal activity. The elevated concentration of K+ causes 
hyperpolarization, which leads to vasodilatation of smooth muscles of arterial walls. The 
increased arterial diameter allows local hyperemia in the regions of the brain, which are 
active at the time, and thus better oxygen and glucose supply (Knot, Zimmermann and 
Nelson, 1996).  
However, the functional hyperemia is not mediated only by K+ ions. It strongly 
depends on astrocytic activation by local release of neurotransmitters, such as glutamate 
(Zonta et al., 2003). The vasodilatory effect was noticed also in connection with arachidonic 
acid metabolites or astrocytic calcium signaling (Takano et al., 2006). The intracellular 
concentration of calcium [Ca2+]i in astrocytes is elevated in response to neuronal stimulation 
as a result of removal neurotransmitters from synapses, and [Ca2+]i has an oscillating 
character. These oscillations can change into so-called calcium waves, which propagate 
through the astrocytic network (Cornell-Bell et al., 1990). The increased [Ca2+]i in astrocytes 
means an increased [Ca2+]i in endfeet of the activated cells, which leads to its release via 
specific channels. These calcium signals correlate with enlarged arterial diameter 
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(Zonta et al., 2003). The vasoactive effect of Ca2+ is not limited only to vasodilatation. It was 
demonstrated, that Ca2+ can cause also vasoconstriction (Mulligan and MacVicar, 2004). The 
resulting effect of calcium signaling on the brain arterioles seems to depend on the size of 
calcium wave and activation of signaling pathways with opposing roles in vascular 
endothelium (Mulligan and MacVicar, 2004). 
3.4.3 Astrocyte swelling 
Astrocytic endfeet at both the glia limitans and surrounding parenchymal blood 
vessels have been well documented to play a role in astrocytic volume changes via movement 
of osmolytes and water. Molecules also move through the panglial syncytium through 
contacts with both oligodendrocytes and with neighboring astrocytes. Uptake of osmolytes at 
synapses is also involved in alterations in astrocytic volume.  
Astrocytic swelling is a complex process, which includes activation of a large number 
of membrane channels and transporters. These mediate influx of osmotically active solutes, 
including K+, Na+ or Cl-. The ions can move through plasmatic membrane via channels, such 
as Na+/K+/Cl--cotransporter type 1 (NKCC1), TRPV4, inwardly rectifying potassium 
channels type 4.1 (Kir4.1), Na+/K+-ATPase or sulfonylurea receptor 1 (SUR1) associated 
with transient receptor potential melastatin 4 (TRPM4; Fig. 3). Ions then move through the 
panglial syncytium via connexin hemichannels. Osmotic gradients are also increased by 
uptake of glutamate from active synapses. Water follows these solutes via AQP4 water 
channels as well as through connexins and the cells swell. Individual astrocytes differ in their 
ability take up water and ions, because of a variability in expression of above mentioned 
membrane proteins. The astrocyte swelling is followed by RVD. In this process TRPV4, 
NKCC1 and anion channels such as volume regulated anion channels (VRAC/LRRC8), 
chloride channels type 2 (ClC-2) are supposedly involved. They remove ions from astrocyte 
cytoplasm. It causes water efflux from the cells and  results in astrocytic volume decrease 
(reviewed in Lafrenaye and Simard, 2019).  
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Figure 3: Astrocyte swelling and volume regulation involve multiple complex processes. (A) 
Illustration depicting the major sites associated with movement of osmotically active molecules into 
and out of astrocytes influencing astrocyte swelling. The potential localization of channels reported to 
regulate astrocyte swelling and/or volume decrease are also depicted; however, exact subcellular 
localization for many of these channels remains to be determined. (B) Summary of channels mediating 
astrocyte swelling (red channels) or regulated volume decrease (RVD; blue channels). Yellow 
channels are involved in both swelling and RVD. During astrocyte swelling, the channels colored red 
are involved in mediating the influx of ions and osmotically active molecules (red arrows). Swelling 
involves K+ ions moving into the cell via Cx43 gap junctions and hemichannels, Kir4.1 and 
Na+/K+-ATPase. The NKCC1 and SUR1-TRPM4 channels allow the influx of multiple ions, including 
K+, Na+ and Cl−. Glutamate movement into astrocytes through transporters and Ca2+ influx through 
TRPV4 channels also increases the osmotic gradient leading to water movement into swelling 
astrocytes through AQP4 channels. Following swelling, the channels colored blue are involved in 
reducing astrocytic volume and expelling osmolytes (blue arrows). Upon RVD, K+ moves out of 
individual astrocytes via Cx43, and Kir4.1 channels. Both ClC-2 and LRRC8/VRAC channels remove 
Cl− from astrocytes resulting in water movement out of astrocytes through AQP4 channels. The 
TRPV4 and NKCC1 channels also might play roles in mediating astrocyte volume decrease, however, 
the mechanisms by which this happens are not yet understood. It is important to note that astrocyte 
swelling and RVD are complex processes with multiple players that may or may not act together in 
any given situation and/or following any particular pathological event and that our knowledge 
regarding many of these mechanisms is still limited, therefore parts of this figure are speculative. 
Taken from (Lafrenaye and Simard, 2019). 
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3.4.4 Reactive astrocytosis 
Astrocytes are known to play an important role in brain pathologies and injuries. They 
are able to undergo a dramatic change and transformation called ‚reactive astrocytosis‘. It is a 
state characterized by complex changes in gene expression, leading to changes in 
morphology. It is still discussed, whether reactive astrocytes are beneficial or harmful for the 
injured brain. They were proven to have both protective as well as damaging role. Reactive 
astrocytes protect tissue after an injury by building a barrier (glial scar) around the site of 
damaged tissue. Astrocytes are essential for BBB repair and recovery and their deletion of 
causes wide spread tissue disruption and degeneration (Faulkner et al., 2004). On the 
contrary, reactive astrocytes inhibit axonal reparation and sprouting (spontaneous growth of 
neurons in response to injury) (Brambilla et al., 2009) and modify the extracellular matrix 
causing a glial scar formation (Zamanian et al., 2012). Astrocytes in healthy brain induce 
synapse formation, while in reactive astrocytes such ability is reduced. They do induce 
synapse formation, but fewer and those are weaker, compared to the healthy brain (Liddelow 
et al., 2017). 
Reactive astrocytosis is characterized by molecular changes. All reactive astrocytes 
show increased GFAP and vimentin (intermediate filament protein) immunoreactivity that 
persists for at least a week after the injury (Zamanian et al., 2012), and increased level of 
AQP4 (Saadoun et al., 2005). Their final transcriptome depends on the nature of the injury or 
pathology. Every astrocyte responds to the injury a little bit differently and most of the 
changes are transient. They are also able to divide, but this ability is limited and is delayed to 
the primary insult (Zamanian et al., 2012). The molecular changes also suggest that reactive 
astrocytes posses the ability of phagocytosis, helping to decrease the amount of cellular waste 
accumulated due to brain injury (Morizawa et al., 2017).  
 
4 Aquaporin 4 
 
Aquaporin 4 is a member of the aquaporin protein family, which was described by 
Peter Agre and his colleagues in 1990s.  His laboratory identified an integral membrane 
protein in red blood cells, which they named CHIP28. This protein was selective for water 
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and was reversibly inhibited by mercuric chloride (Preston et al., 1992). Later other water 
channels were identified not only in vertebrae, but also in plants and other groups of 
organisms, and today a whole family of aquaporins is known. This family consists of two 
main groups of channels: aquaporins (which are specifically permeable for water only) and 
aquaglyceroporins (permeable for water and small nonpolar solutes, such as glycerin) (Agre 
et al., 2002).  
4.1 Structure and localization 
Aquaporins are small channels with six transmembrane helixes and two semi-helixes, 
usually functioning as tetramers. Each type of aquaporin has a specific tissue expression 
pattern (Agre, 2006; Papadopoulos and Verkman, 2013). AQP4 is one of three aquaporins 
found in the brain, but the only one which was described in mice on astrocyte membranes and 
on a subpopulation of ependymal cells (Nielsen et al., 1997). AQP4 is expressed in several 
isoforms: M1, M23, Mz, AQP4e. The major isoforms (M1 and M23) vary because of 
different translation initiation (more than one methionine codon is part of the genetical 
sequence of 5‘ untranslated region). These polypeptides of ~32 and ~34 kDa in length, differ 
in 22 amino acids at the N-terminus (Neely et al., 1999; Furman et al., 2003; De Bellis et al., 
2017; Lisjak et al., 2017) – Fig. 4. These different isoforms indicate functional heterogeneity 
or different localization of each polypeptide. AQP4 assembles into homo- and 
heterotetramers. The tetramerization requires intracellular part of the polypeptide called 
D-loop. These loops of each subunit interact and stabilize the whole tetrameric structure 
(Kitchen et al., 2016). Different tetramers have the same water permeability, specified by a 
highly conserved amino acid motif of asparagine-proline-alanine, but can vary in regulatory 
mechanisms (different phosphorylation sites) and in their localization within the brain (Neely 
et al., 1999; Agre et al., 2002). It was demonstrated that tetramerization is not required for 
AQP4 trafficing into the plasma membrane, however, the non-tetrameric forms are not able 
to respond to local osmolarity changes (Kitchen et al., 2016). The different pool of each 
isoform also indicates that cells are able to regulate their expression as a follow up to specific 
conditions and homeostatic needs (Nicchia et al., 2010; De Bellis et al., 2017).  
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Figure 4: Sequence and structural features of AQP4. a) The primary amino acid sequence and 
membrane topology of AQP4. AQP4 has six transmembrane helixes and two semi-helixes, which are 
labeled M1 – M8. Two translation initiation sites on N terminus — Met1 and Met23 (black) — 
correspond to the two main AQP4 isoforms, M1 and M23. AQP4 tetramers can form orthogonal 
arrays of patricles (OAPs) through intermolecular N-terminal associations between M23 isoforms 
involving the residues highlighted in purple. The residues in green prevent N-terminal associations 
between M1 AQP4 molecules. Cysteine residues (in blue) are sites of palmitoylation, and are 
involved in regulating OAP assembly. b) X-ray crystal structure of human AQP4 shows the eight 
membrane helixes. c) Freeze-fracture electron micrograph of M23-AQP4-OAPs (left panel). The 
middle panel shows a super-resolution micrograph of cells co-expressing a green fluorescent variant 
of M23-AQP4 and a red fluorescent variant of M1-AQP4. From such micrographs, it has been 
determined that OAPs have a M23-AQP4-enriched core, with M1-AQP4 being found in the 
periphery of these structures. Taken from: Papadopoulos and Verkman, 2013. 
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The expression of AQP4 on astrocyte membranes is highly polarized. Using 
immunolabeling techniques, AQP4 was found to be predominantly expressed on endfeet, i.e. 
the processes in direct contact with blood vessels, and in glia limitans (Nielsen et al., 1997; 
Neely et al., 1999). On this membranes, the expression is so strong, that AQP4 tetramers can 
assemble into supramolecular structures, called orthogonal arrays of particles (OAPs) (Rash 
et al., 1998; Neely et al., 1999; Sorbo et al., 2008). These are formed from ~ 6nm 
intermembrane particles, which can be separated or create clusters (OAPs). In one OAP up to 
100 tetramers can be found (Furman et al., 2003; Smith and Verkman, 2015). The size of 
each OAP is determined by the ratio between AQP4 isoforms (Sorbo et al., 2008; Nicchia et 
al., 2010; De Bellis et al., 2017). When expressed alone, the M1 and Mz isoforms create 
isolated particles, contrary to M23, which forms large OAPs – Fig. 4. But all isoforms 
expressed together form average size OAPs, with the size dependent on the isoforms ratio 
(Sorbo et al., 2008; Nicchia et al., 2010; Smith and Verkman, 2015). The supramolecular 
assembly is also a determinant of subcellular localization of the AQP4 tetramers. The large 
OAPs seems to be preferentially expressed on astrocyte endfeet, while the separate tetramers 
and smaller clusters localize on the other parts of astrocytes and on the cells, which are not in 
the direct contact with capillaries (Smith and Verkman, 2015). The polarization of AQP4 
expression and its localization on blood-brain interface is dependent on α-syntrophin, a 
protein, which anchors OAPs in the membranes on the astrocyte-capillary interface (Neely et 
al., 2001). In animals lacking α-syntrophin the total level of AQP4 expression is unaltered, 
but its molecules are not so specifically localized as a part of BBB (Neely et al., 2001).  
Besides α-syntrophin, AQP4 is suspected of creating supramolecular complexes with 
other channels. One of them is Cx43. Cx43 is the main protein creating gap junctions in the 
brain and thus allows water and ions to redistribute within the astrocytic syncytium. 
However, its functional connection with AQP4 remains unclear, because in literature 
contradictory opinions can be found. In cultured neonatal mouse astrocytes knocking down 
the AQP4 gene caused strong down-regulation of Cx43, but in human cortical cultured 
astrocytes, the protein levels were not altered (Nicchia et al., 2005). On the contrary, the 
number of Cx43 - together with Cx30 - was increased in adult brain tissue of AQP4-deficient 
mice (Katoozi et al., 2017), showing probably some kind of developmental regulation. 
Furthermore, AQP4 was described to create a complex with TRPV4 in cultured cells 
(Benfenati et al., 2011) and in Muller glia in the retina (Jo et al., 2015), as well as a complex 
with Kir4.1 (Jo et al., 2015). The latest, however, does not include any functional coupling 
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between AQP4 and Kir4.1. It seems to be the matter only of high protein expression within 
the BBB (or blood-retina barrier) (Zhang and Verkman, 2008), but the results remain unclear.  
4.2 AQP4 in brain pathologies 
AQP4 is studied intensively, because of its crucial role in many brain pathologies, 
such as brain edema and ischemia, non-specific complications accompanying other diseases 
and injuries, such as stroke, traumatic brain injury, tumors or liver failure (Klatzo, 1987; 
Unterberg et al., 2004). Interestingly, AQP4 seems to play opposite roles in both types of 
brain edema. Its localization on astrocyte endfeet makes AQP4 an essential part of BBB and 
thus an influx route for water in pathological conditions of the vasogenic edema (Camassa et 
al., 2015), which is caused by increased permeability of brain capillaries and thus by BBB 
disruption. Serum proteins enter the brain parenchyma without limitations and cause a 
massive water influx, even through undamaged parts of brain capillaries. This results in 
expansion of extracellular space and compression of cellular compartments of the brain 
tissue. The process of water accumulation also causes an increase in intracranial pressure 
(Fishman, 1975; Klatzo, 1987). In a healthy brain, the extracellular fluid is eliminated 
through glia limitans (and through AQP4 channels) and into subarachnoid space, as well as 
into capillaries and cerebrospinal fluid (Fenske and Prioleau, 1978; Tait et al., 2008). In the 
case of vasogenic edema, the AQP4-deficient mice have shown a significant increase in brain 
water content. In these mice, physiological water elimination via AQP4-rich glia limitans 
does not occur and water accumulates within the brain parenchyma (Manley et al., 2004; 
Tang et al., 2010). On the contrary, the outcome of cytotoxic edema in AQP4-deficient mice 
is better, compared to the wild-type animals. The role of AQP4 in pathological cytotoxic 
swelling was demonstrated in several studies using AQP4-deficient mice, showing improved 
outcomes in models of ischemic brain injury, such as MCAO (Yao et al., 2015; Hirt et al., 
2016). These mice have significantly lower mortality, compared to the wild-type mice, as 
well as significantly smaller lesion volume (Manley et al., 2000; Akdemir et al., 2014; Katada 
et al., 2014; Yao et al., 2015; Hirt et al., 2016). Stroke or traumatic brain injury usually leads 
to reactive astrocytosis. This process is influenced by many factors, and one of them is the 
presence/absence of AQP4. Reactive astrocytes are able to migrate to the specific area of the 
damage and this ability, and the glial scar formation itself is disrupted in AQP4-deficient 
mice (Saadoun et al., 2005).  
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AQP4, however, plays an important role also in other brain pathological states, such 
as neuromyelitis optica (NMO). It is an autoimmune demyelinating disease affecting 
predominantly optic nerves and spinal cord. In serum of patients with NMO, a specific 
immunoglobulin type G (IgG) was found. This antibody binds to capillaries and to the 
subpial surface of the brain, where AQP4 is strongly expressed (Lennon et al., 2005). Recent 
extensive research indicates, that AQP4 has its role even in processes leading to depression 
(Kong et al., 2014) or in the long-term memory (Fan et al., 2013). 
4.3 Regulatory volume decrease 
AQP4 and other proteins in close coupling with AQP4 such as TRPV4 or Kir4.1, are 
considered to be the key players in the process of astrocytic regulatory volume decrease 
(RVD), which occurs during in cytotoxic edema and comprises an efflux of osmolytes, such 
as taurine, aspartate and Cl- (Benfenati et al., 2011; Mola et al., 2017). Cytotoxic edema is 
caused by homeostatic imbalance and leads to water accumulation inside the cells 
(Baethmann, 1978). Astrocytes are able to react to the pathological hypoosmotic conditions 
by stimulating AQP4 expression and thus by forming new OAPs and by redistributing AQP4 
proteins within the cells, as was described on astrocyte cultures (Lisjak et al., 2017). That 
affects the dynamics of water transport in brain parenchyma and leads to the RVD. Astrocytic 
response to the extracellular hypotonicity involves an increase in [Ca2+]i (Benfenati et al., 
2011), which is, however, just a consequence of increased permeability of the plasma 
membrane and it does not function as an intracellular signal (Morales-Mulia et al., 1998). 
The process of RVD might involve also other protein channels, such as Kir4.1 or TRPV4.  
 
5 Transient Receptor Potential Vanilloid 4 channels  
  
TRPV4 is a member of transient receptor potential (TRP) channels family, a large 
class of proteins, which is widely distributed in mammalian tissues and have a wide range of 
functions. TRP channels are permeable for monovalent cations and for Ca2+, which makes 
them an important component of Ca2+ signaling pathways (reviewed in Clapham, Runnels 
and Strübing, 2001).  
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TRPV4 is a tetrameric channel with structure homologous to other members of the 
TRPV family (Shigematsu et al., 2010). It has 5 splicing variant with alternations in the 
N-terminal region (Arniges et al., 2006) and individual subunits can assemble into homo- or 
heterotetramers. The assembling can influence TRPV4 localization or modify the functioning 
of these channels. The similar effect has an alteration in the C-terminal domain (Arniges et 
al., 2006; Becker et al., 2008; Deng et al., 2018). Through N-terminus the TRPV4 channels 
are able to interact with other effector proteins, that modify their activity and the activity of 
downstream signaling cascades (Garcia-Elias et al., 2013). One of such proteins is 
phosphatidylinositol-4,5-bisphosphate (PIP2). Its role in TRPV4 activation/deactivation, 
however, remains unclear. Harraz and colleagues suggested, that in capillary endothelium in 
brain PIP2 inhibits TRPV4 channels and this inhibition can be reversed by reducing PIP2 
concentration in endothelial cells (Harraz et al., 2018). On the contrary, Garcia-Elias et al., 
2013 found, that PIP2 binds to TRPV4 through a binding site in N-terminal domain and such 
interaction rearranges intracellular domains of TRPV4 leading to its activation. 
5.1 TRPV4 functions 
TRPV4 channel is a polymodal receptor and is able to respond to various stimuli, 
such as cell swelling, acidity changes or mechanical stress (reviewed in Kanju and Liedtke, 
2016). As a member of the TRP family, TRPV4 channel is temperature sensitive, with its 
optimum between 27 – 37°C (Güler et al., 2002; Watanabe et al., 2002). It has a wide range 
of functions across various tissues. In the brain, it was reported to stimulate OPCs 
proliferation via its activation. Thus TRPV4 channels may be involved in brain development 
and plasticity (Ohashi et al., 2018). Besides OPCs, TRPV4 is expressed also on other cell 
types in CNS and through most of the mammalian tissues. 
TRPV4 channels are expressed on neuronal membranes, where they play an important 
role as osmosensors and thus are involved in neuronal volume regulation. TRPV4 activation 
leads to Ca2+ influx into the neurons and this Ca2+ entry acts as an activating signal for other 
ion channels. TRPV4 channels were shown to functionally couple with Ca2+-activated K+ 
channels (KCa) and their activity causes an influx of K
+ into the neurons resulting in their 
hyperpolarization (Feetham et al., 2015).  
TRPV4 channels are expressed also on astrocytic membranes, however, its expression 
is restricted to about 20 – 30 % of astrocytes within the brain (Shibasaki et al., 2014). 
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TRPV4-positive astrocytes are suspected to play a role in the synchronization of neuronal 
excitability via a release of regulating proteins (so-called gliotransmitters), such as adenosine 
triphosphate or glutamate (Shibasaki et al., 2014). These channels also influence 
neurovascular coupling (NVC). This term describes a close relationship between neuronal 
activity and vascular dilatation/constriction, with astrocytes as an intermediate. This process 
is partially mediated by Ca2+ (and thus by TRPV4 channels), which is released from 
astrocytic endfeet and causes vasoconstriction (Mulligan and MacVicar, 2004). NVC is also 
regulated via a release of K+ and nitric oxide (Kenny, Plank and David, 2018).  
5.2 TRPV4 in brain pathologies 
TRPV4 channels play their role in brain pathologies and they even have their role in 
channelopathies, which are hereditary and affect TRPV4 functions. Most of them do not 
affect CNS, but are of motoric nature, affecting lungs or PNS (reviewed in Nilius and Voets, 
2013). In CNS, this channel is also involved in demyelinating diseases (Liu et al., 2018). 
TRPV4 channels provide a bidirectional pathway for Ca2+ and their activation 
increases Ca2+ signaling in astrocytes as well as cell membrane depolarization (Lipski et al., 
2006; Dunn et al., 2013; Rakers, Schmid and Petzold, 2017). Ca2+ signaling is increased in 
ischemic conditions, because TRPV4 channels are known to respond to various stimuli 
occurring during ischemic events, such as membrane stretch and changes of pH. The 
pathological state such as global cerebral ischemia also leads to upregulation of TRPV4 
expression on astrocytes (Butenko et al., 2012). This modulates functioning of signaling 
pathways, that regulate cell death and survival, such as mitogen-activated protein kinase 
(MAP-kinase) pathway. During ischemia, TRPV4 channels were shown to amplify tissue 
damage and BBB disruption via over-activation of apoptotic pathways (Pinghui Jie et al., 
2015). Using TRPV4 antagonist reduced brain-infarction area after MCAO of about 30 % in 
mice (P. Jie et al., 2015).  
TRPV4 channels are suspected to function as a complex with AQP4 channels (Fig. 5). 
AQP4 and TRPV4 are trafficked independently to the membrane, and also their activation 
and functioning can be autonomous (Jo et al., 2015). But in cultured astrocytes and in Muller 
glia in retina, these channels were shown to colocalize (Benfenati et al., 2011; Jo et al., 
2015). Because of this colocalization, both channels are supposed to be key players in the 
process of astrocytic RVD. This osmoregulating complex can be the link between cell water 
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permeability and Ca2+ homeostasis, that seems to be the trigger for a cellular response, 
leading to RVD or even to apoptosis (Iuso and Križaj, 2016). It is even hypothesized that 
RVD cannot occur without both components present on the membrane (Benfenati et al., 
2011). Taken together, this indicates, that TRPV4 is an important player in astrocytic Ca2+ 
signaling events during ischemia (Rakers, Schmid and Petzold, 2017).  
 
Figure 5: Proposed schema of TRPV4 – AQP4 interactions in the Müller cell endfoot. Hypotonic stress 
stimulates fluxes of water after the osmotic gradient. The resulting increase in cell volume stretches the 
plasma membrane, activating TRPV4 and a Ca2+ and stretch-sensitive phospholipase A2 (PLA2). The 
product, arachidonic acid (AA), is a precursor for the cytochrome P450-mediated synthesis of 
eicosanoid metabolites (EETs) that serve as final activators of TRPV4 channels but may also suppress 
Kir4.1 The expression of Kir4.1 and reactive gliosis are modulated by hypotonic stimulation-induced 
influx of Ca2+. It remains to be determined whether stretch activates PLA2 simultaneously with TRPV4 
or whether its activation, which is Ca2+-dependent, amplifies the initial TRPV4 signal (blue arrows). 
Ca2+ induces both cell swelling (short term) and RVD (long term) and may be required for 
Ca2+ dependent gene expression (Aqp4, Kir4.1, Trpv4, Gfap). High levels of Ca2+ may also stimulate the 
activity of big potassium (BK) and VRAC channels and facilitate RVD. Taken from: Jo et al., 2015. 
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6 Methods 
6.1 Animals 
Experiments were performed on GFAP/EGFP transgenic mice (line designation 
TgN(GFAP-EGFP), FVB background), in which the expression of enhanced green 
fluorescent protein (EGFP) is controlled by the human GFAP promoter (Nolte et al., 2001). 
These animals were either crossed with the TRPV4-deficient strain (on C57BL/6N 
background) with excised exon 12 encoding transmembrane pore domains 5 and 6 (Liedtke 
and Friedman, 2003) or with AQP4-deficient mice. Those were generated as previously 
described Ikeshima-kataoka et al., 2013 and frozen embryos were obtained from Riken BRC 
(acc. no. CDB0758K-1; http://www.cdb.riken.jp/arg/mutant%20mice%20list.html; genetic 
background B6 mixed with Balb/c) and derived by a licenced carrier to the Czech Republic, 
were breeding lines were established through embryo transfer. Homozygous TRPV4- and 
AQP4-deficient lines were established together with homozygous TRPV4- and AQP4-
positive lines, used as controls. 
All procedures involving the use of laboratory animals were performed in accordance 
with the European Communities Council Directive 24 November 1986 (86/609/EEC) and 
animal care guidelines approved by the Institute of Experimental Medicine, Czech Academy 
of Sciences (Animal Care Committee on April 7, 2011; approval number 018/2011). All 
efforts were made to minimize both the suffering and the number of animals used. 
6.2 Acute brain slices preparation 
Astrocytic volume was quantified in situ in four groups of mice (both male and 
female) of the age of 90 ± 10 days. Animals were anaesthetised using intraperitoneal 
injection of pentobarbital (100 mg/kg) and than transcardially perfused with cold (4 ± 1 °C) 
isolation solution (Tab. 1). Perfused animals were decapitated and the brains were quickly 
removed. Acute coronal slices were prepared from each brain (300 µm thick) on a vibrating 
microtome (HM 650 V, Thermo Scientific Microm, Walldorf, Germany). The slices were 
kept in preheated (34°C) isolation solution for 30 minutes and than for another 30 minutes at 
room temperature in arteficial cerebrospinal fluid (aCSF; Tab. 1). Before microscopic 
scanning, every slice was incubated for 10 minutes in preheated aCSF (34°C), and kept 
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heated also during the measurement (32 ± 1 °C). Both isolation solution and aCSF were 
bubbled with 95% O2 / 5% CO2, pH 7.4, osmolality was measured using a vapor presure 
osmometer (Vapro 5520, Wescor, Logan, UT). 
 
Table 1: Composition of the experimental solutions. All the concentrations are in mM. 
Contents Isolation 
solution 
aCSF Hypotonic 
solution 
OGD 
NaCl - 122 67 122 
NMDG-Cl 110 - - - 
KCl 3 3 3 3 
NaHCO3 23 28 28 28 
Na2HPO4 1.25 1.25 1.25 1.25 
CaCl2 0.5 1.5 1.5 1.5 
MgCl2 7 1.3 1.3 1.3 
Glucose 20 10 10 - 
Osmolarity 
[mOsm/kg] 
~300 
 
~300 ~200 ~300 
Saturated with 95% O2 
5% CO2 
95% O2 
5% CO2 
95% O2 
5% CO2 
5% O2 
5% CO2 
90% N2 
 
 
6.3 Three-dimensional multiphoton morphometry in situ  
Fluorescent images were acquired from acute brain slices using multiphoton laser 
scanning microscope FV1200MPE (Olympus) with 60x LUMPLFLN water objective. 
Fluorescence of EGFP was excited by 950 nm and the signal was detected using appropriate 
emission filters. Whole cells (cortical layer 2 – 5 astrocytes) were imaged as a set of focal 
images (Z-stack) with a constant spacing/step size of 0.5 µm. Approximately 150 – 200 focal 
images were acquired for every cell. Five Z-stacks were acquired before the experiment, for 
correction of scanning photobleaching. Then two sets of images were acquired 10 and 20 
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minutes after application of hypotonic solution/OGD solution (Tab. 1) and another two sets 
of images after repeated application of aCSF (10 and 20 minutes) – (Awadová et al., 2018; 
Pivonkova et al., 2018; Fig. 6).  
 
Figure 6: Schematic representation of our experimental protocol. Red circles represent each image 
acquisition. At the beginning of every experiment we acquired 5 sets of images for photobleaching 
correction (left green part, test 1 – 5). Afterwards the slices were placed in the hypotonic or OGD 
solution and the Z-stacks were acquired every 10 minutes (Hypo/OGD 10, 20). Then the aCSF 
application was repeated in washout phase and Z-stacks were acquired after 10 and 20 min of the 
application (Wash 10, 20). 
6.4 Quantification of astrocytic volume changes 
Quantification of cellular volume changes was performed using several methods. 
Those were described in separate methodological publication (Awadová et al., 2018). Firstly 
we used an custom-made CellAnalyst program (Chvátal, Anděrová and Kirchhoff, 2007). 
The cell boundary was determined in each x-y frame using an intensity-based edge-detecting 
algorithm, and the area of the image surrounded by the edge was calculated for each layer. 
From these data, cell volume was obtained by integrating the values of all images in a stack 
(Awadová et al., 2018). Second method we used was fluorescence intensity-based cell 
volume quantification in the cell soma (Awadová et al., 2018; Pivonkova et al., 2018). Image 
processing and morphometry measurements were performed using the ImageJ/Fiji software 
(https://fiji.sc/). From all time courses (9 Z-stacks) for one cell average fluorescence intensity 
projections along the z-axis were created. For projections we used only astrocytic soma. 
These projections were used for creating another stack of images, where the somata were 
aligned. The intensity of fluorescence was measured from circular selection (~ 2µm in 
diameter) from the cell soma (the selection was the same through all the time courses of one 
cell). Since the fluorescence intensity decreases proportionately to the swelling of the cells, 
we counted the cellular volume as 1/fluorescence intensity. 
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The astrocyte volume at t = 0 min (test5) was set to 100% and the astrocytic swelling 
was expressed relative to this baseline as an increase in percentage.  
6.5 Quantification of volume changes in astrocytic endfeet 
The endfeet thickness was measured from Z-stack images, as was the astrocyte 
volume. From the Z-stacks average projection was created in FIJI, using 3 slices, where the 
endfeet appeared the thickest. In these projestions the diameter of the endfeet was measured. 
Data were converted to relative numbers and statistically evaluated. Again, the astrocyre 
endfeet at time 0 (test 5) was set to 100 % and the volume changes were expresed relative to 
this baseline as an increase in percentage.  
6.6 Statistics 
The data are shown as mean ± standard error of the mean (SEM) for n cells. Two-way 
ANOVA with Bonferroni’s multiple comparison post-test was used to evaluate significant 
differences in cellular volume. Values of p < 0.05 (*; #) were considered significant, p < 0.01 
(**; ##) very significatnt and p < 0.001 (***; ###) extremely significant. 
 
7 Aims of the study 
 
AQP4 and TRPV4 channels are both involved in astrocytic volume regulation in 
vitro, as described Benfenati et al., 2011, Iuso and Križaj, 2016. Therefore we hypothesised 
that similar involvement in astrocytic volume regulation should be visible also in situ in acute 
brain slices. In the the present diploma theses, we aimed to clarify roles of AQP4 and TRPV4 
channels in situ in single astrocytes in two different pathological stimuli – hypotonic stress 
and OGD. We also aim to compare our results from acute brain slices with the known data 
from cultured cells and to adress possible differences in astrocytic volume regulation in vitro 
and in acute brain slices (in situ). 
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8 Results  
8.1 Quantification of cell volume changes 
First we compared different methods of cellular volume quantification. Since our 
initial measurements revealed that the astrocytic volume changes detected at 30 – 32°C are 
too extensive, we were not able to quantify the cell volume using 3D morphometric approach. 
Therefore we decided to compare several methods to select the most reliable one. The first 
method uses a 3D morphometric analysis of the Z-stacks of images, which leads to the direct 
cell volume assessment (Chvátal, Anděrová and Kirchhoff, 2007). The second method 
derives the volume changes from area accupied by the cells in a single two dimensional (2D) 
image. The last approach uses the local intensity of fluorescence, which is proportional to the 
concentration of the fluorophore in the whole cell and is also inversely proportional to the 
cell volume.  
The performance of the three volumetric methods - 3D morphometry, 2D 
morphometry and fluorescence intensity measurements – was first checked in two adherent 
cell cultures with different cell-shape characteristics. On the one hand, we chose 3T3 murine 
fibroblasts as an example of compact, morphologically well-defined cells with a vast majority 
of the cell volume concentrated in the close vicinity of the cell nucleus. On the other hand, a 
culture of cortical astrocytes isolated from a brain of GFAP/EGFP mice was chosen. Even in 
the single-layer adherent culture, the astrocytes develop numerous processes, which typically 
Figure 7: Cells in cultures undergoing 
volume changes induced by osmotic 
treatment. Representative lateral setion of a 
singlecalcein loaded murine fibroblast (A) 
and cortical astrocyte of GFAP/EGFP mouse 
in the culture (B, C) before the treatment 
(left), 10 min after the application of either 
hypotonic (205mOsm/kg; A, B) or 
hypertonic (405 mOsm/kg; C) solution 
(middle), and 5 min after the washout with 
isotonic solution  (right) are presented. 
Bars: 10 µm. Taken from: Awadová et al., 
2018. 
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protrude many tens of micrometers from the globular soma, frequently branch, are not easily 
trackable in the culture, and markedly contribute to the cell volume (compare the different 
cell morphologies illustrated in Fig. 7).  
Fibroblasts were preloaded with one of the accepted volume indicators, calcein-AM. 
Calcein-AM represents a small, plasma membrane-permeable dye that is cleaved by 
intracellular esterases. Membrane-impermeant fluorescent cleavage product then stays in the 
cytoplasm. GFAP/EGFP mouse is a transgenic mouse, the astrocytes of which are labeled by 
EGFP expressed under the control of the cell-type specific, human glial fibrillary acidic 
protein promoter (Nolte, 2001). In both cultures, the cell volume increase was induced by a 
standard hypotonic treatment (see Methods for detailed description). The hypotonicity-
Figure 8: Quantitative analysis of cell 
volume changes in cell cultures. Relative 
cell volume in a culture of calcein-loaded 
murine fibroblast (A) and cortical astrocytes 
of GFAP/EGFP mice in the culture (B, C) 
as reported by 3D morphometry (3D, white 
bars), lateral cell size measurements (2D, 
gray) and fluorescence intensity 
measurements (FI, black) are plotted in 
charts. Mean values ± SEM are presented 
(n = 32, 28 and 17 in A, B, C respectively). 
Numbers along the horizontal axis indicate 
the time (in min) after the last exchange of 
the media. Taken from: Awadová et al., 
2018. 
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induced swelling of individual cells was measured by the three aforementioned approaches as 
described in the Methods.  
In both analyzed cultures, the treated cells exhibited a maximal swelling 4 min after 
the application of the hypotonic solution. This rapid volume increase was successfully 
detected by all three approaches (Fig. 8). In the fibroblast culture, 3D morphometry and 
fluorescence intensity methods produced identical results with a maximal volume increase by 
25 ± 2% and 23 ± 2% of the initial cell volume, respectively, while the 2D morphometry 
approach reported somewhat higher values of the volume increase with the maximum at 38 ± 
3%. After the isotonic washout, all of the three methods reported a nice restoration of the 
initial fibroblast volume (Fig. 8A). In the culture of cortical astrocytes, only the fluorescence 
intensity measurement was able to report comparable swelling amplitudes, with the 
maximum of 30 ± 3% (4 min after the hypotonic shift) and equilibrium at 22 ± 2% (≥8 min). 
Morphometric approaches detected lower swelling amplitudes with maxima of 19 ± 3% and 8 
± 2% for 2D and 3D morphometry, respectively. Both of the morphometric approaches 
apparently underestimated the cellular volume following the isotonic washout at the end of 
the experiment (Fig. 8B).  
The changes in the cellular volume were quantified in a culture of cortical astrocytes 
from GFAP/EGFP mice by the three volumetric approaches. Again, all three approaches were 
capable of detecting the cell shrinkage (Fig. 8C) and again, the 3D morphometric approach 
revealed the smallest amplitude of the registered volume change of -7 ± 1%. The shrinkage 
detected by 2D morphometry and fluorescence intensity approaches were significantly (p < 
0.001) larger, −21 ± 2% and −13 ± 2%, respectively.  
Next, we compared the outputs of the three volumetric approaches in monitoring the 
osmotically induced volume changes of astrocytes in acute brain slices of GFAP/EGFP mice. 
Astrocytes in acute brain slices are cells of a highly complex architecture. Tracing their 
borders thus represents a serious challenge for morphometric algorithms (Bindocci et al., 
2017). The application of hypo- and hypertonic treatment induced significant, but to a high 
extent reversible changes in the 3D morphology of these cells (Fig. 9). As expected, we 
observed much higher rates of astrocytic swelling in hypotonically treated brain slices, if 
compared to the astrocytes in the culture. After 20 min of the hypotonic treatment, 3D 
morphometry, 2D morphometry and fluorescence intensity measurements indicated a cell 
volume increase by 53 ± 7%, 105 ± 4%, and 107 ± 8%, respectively. All three approaches 
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also detected a significant (p < 0.001) decrease of the cell volume towards the original value 
following the re- application of the isotonic solution (Fig. 10A).  
Figure 10: Quantitative analysis of cell volume 
changes in acute brain slices. Relative volume 
changes in acute brain slices of GFAP/EGFP mice 
induced by hypo- (A) and hypertonic treatment (B) as 
reported by 3D morphometry (3D, white bars), lateral 
cell size measurements (2D, gray) and fluorescence 
intensity measurements (FI, black) are reported in 
charts. Mean values ± SEM are presented (n = 49 and 
13 in A and B, respectively). Numbers along the 
horizontal axis indicate the time (in min) after the last 
exchange of media. Taken from: Awadová et al., 
2018. 
 
Figure 9: Osmotic treatment-induced changes of the astrocytic volume in acute brain slices. Maximum 
intensity projection of representative cells in acutebrain slices of GFAP/EGFP mice before the treatment 
(left), 20 min after the application of either hypotonic (205 mOsm/kg; A, B) or hypertonic (405 mOsm/kg; C) 
solution (middle), and 10 min after the washout with isotonic solution (rigDht) are presented. Bars: 10 µm. 
Taken from: Awadová et al., 2018. 
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The peripheral parts of the astrocytes with a terminally branching bushy network of 
fine processes were hard to trace (Fig. 9), which was especially true in the axial (z) direction 
within the 3D image stacks. A typical astrocyte cell encompassed 150–200 x-y frames on a 
z-stack. It has to be mentioned that, despite the use of a two-photon fluorescence excitation, 
the contrast of the images recorded deeper in the tissue was significantly lower when 
compared to the more superficial ones. The number of frames further increased upon the 
swelling of the brain section during the hypotonic treatment. This fact could contribute not 
only to a significantly (p < 0.001) lower amplitude of the volume changes detected by the 3D 
morphometry method, but also to the relatively high standard deviation of the values 
measured by the 3D morphometry approach in this type of specimen. As an additional control 
of the cell integrity during the osmotic changes applied to the acute brain section, a 
hypertonic solution was applied to the specimen. In this case, only 2D images of the analyzed 
cells were acquired. A comparison of relative cell volume changes, as revealed by 2D 
morphometry and fluorescence intensity, is presented in Fig. 10B. The maximum cell 
shrinkage detected by these approaches was −30 ± 2% and −33 ± 3%, respectively. After 20 
min of isotonic washing, the cell volume was restored to the original values. We concluded 
that the applied osmotic changes did not have a deleterious effect on the integrity of the 
analyzed astrocytes. 
Finally, we analyzed the cell volume changes as registered by the three approaches in 
astrocytes in acute brain slices of GFAP/EGFP mice during hypotonic treatment performed 
either at room temperature (RT, 23 °C), or at a temperature of 32 °C (HT). The samples were 
treated as described above. In HT, a higher amplitude of astrocytic swelling can be expected 
due to various reasons. Among others, plasma membrane biophysics and the activity of 
transport proteins integral to the plasma membrane are temperature sensitive. In agreement 
with our expectations, the registered increase of the cell volume was in general higher in the 
HT samples. After 10 min of the hypotonic treatment, all three approaches registered 
significantly higher astrocyte swelling in the HT samples, when compared to RT. However, 
in the case of the 3D morphology approach, this was the only time point to confirm that. 
Later on, 3D morphology approach reported comparable volume changes for both 
temperatures. We concluded that in contrast to 2D morphology and fluorescence intensity 
approaches, 3D morphometry failed to register temperature-induced increase in the astrocyte 
swelling in this experiment. 
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We compared all the results of methods listed above in vitro and in situ (Fig. 7-10) 
and concluded that fluorescence-based volume measurements were the most reproducible and 
were in fact insensitive to the cell shape complexity. The results of this study were published 
by Awadová et al., 2018. Thanks to the high complexity of astrocytes we decided to use the 
fluorescence-based approach to quantify their volume in our experiments.  
8.2 Volume changes of astrocytes from AQP4- and TRPV4-deficient mice 
 
In order to examine the role of AQP4 and TRPV4 channels in astrocytic swelling we 
quantified cell volume of single astrocytes together with endfeet thickness in situ in cortex of 
adult mice (90 ± 10 days). In total we measured 175 cells of three different goups of animals 
(Control (Ctrl), AQP4-deficient (AQP4-/-), TRPV4-deficient (TRPV4-/-) under two different 
conditions (two pathological stimuli – hypotonic stress and OGD). 
We performed our experiments on GFAP/EGFP mice, both males and females, 
because there were no differences between them in expression of both channels (Liu et al., 
2008). Our experimental protocol included 5 control measurements of each cell, performed in 
aCSF solution for correction of photobleaching of EGFP. Then the hypotonic or OGD 
solution was applied to the brain slices for 20 minutes. This was followed by 20-min phase of 
washout. The images were acquired every 10 minutes (Fig. 11). All the measurements were 
performed in 32 – 34°C, for TRPV4 channels are temperature sensitive and this is within 
their optimum (Güler et al., 2002; Watanabe et al., 2002). 
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Figure 11: Schematic representation of our experimental protocol. A) At the beginnning we 
acquired 5 control stacks of images (tests 1 – 5) to correct photobleaching of EGFP. B) In the next 
phase we applied hypotonic (Hypo) or OGD solution to the brain slice for 20 minutes. We 
measured selected cell every 10 minutes. This was followed by a washout (Wash) phase (C), when 
the slices were returned to the aCSF for 20 minutes. We measured the cells every 10 minutes.  
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8.2.1 Hypotonicity-induced astrocyte swelling 
To test our working hypothesis about astrocyte volume regulations we performed 
experiments in hypotonic conditions, following experimental protocol shown in Fig. 11. All 
groups showed an increase in the astrocytic volume after 10 minutes of application of the 
hypotonic solution, compared to the control measures and the volume continued to rise for 
another 10 minutes (Hypo20) when it reached the average volume of about 200 % of the 
control measurement. All the groups also decreased their volume after the washout phase, 
compared to the maximal swelling after 20 minutes in hypotonic solution (Fig. 12, 13). 
 
8.2.2 Hypotonicity-induced whole-cell swelling of astrocytes from AQP4-deficient 
mice 
We measured astrocyte volume in the acute brain slices of AQP4-/- mice. In total, we 
measured 21 cells from AQP4-/- mice and compared them to the values from 21 cells from 
control animals. Cells from AQP4-/- animals showed significant volume increase after 10 and 
20 minutes of application of hypotonic solution (significance marks not shown, p<0.001), 
their average volume increase reached after 20 minutes of hypotonic conditions 
202.53 ± 10.61 %, and similarly also showed a significant volume restoration after 10 and 20 
minutes of washout phase in aCSF solution reaching 114.7 ± 10.31 % (### p<0.001). On the 
contrary, in controls the volume restoration after washout was visible, but not significant 
(Fig. 12A). When compared to controls, the cells from AQP4-/- mice showed a similar pattern 
of swelling as the control cells (Fig. 12A, 13). 
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Figure 12: Hypotonicity-induced astrocyte swelling. The light green parts represent hypotonic solution 
application, n represents number of cells in each group. A) Astrocytes from AQP4-/- mice show an 
increase in cell volume in hypoosmotic conditions and also a significant cell volume restoration when 
returned to aCSF (###, p<0.001). The same pattern show also cells from TRPV4-/- mice (B). The 
cellular volume was measured from stacks of focal images – Z-stacks (C) with a control measurement 
at the beginning (D) and another four measurements every 10 minutes during hypotonic solution 
application and washout phase (E, F).  
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8.2.3 Hypotonicity-induced whole-cell swelling of astrocytes from 
TRPV4-deficient mice 
Similarly to AQP4-/-, the astrocytes from TRPV4-/- animals swelled significantly 
(significance marks not shown, p<0.001). When compared to controls, the cells from 
TRPV4-/- mice reached about the same average volume after 20 minutes in hypotonic 
conditions. However, the volume increase of astrocytes from TRPV4-/- was slower. After 10 
minutes in hypotonic solution the average volume of TRPV4-/- cells was slightly smaller 
(182.16 ± 9.01 %), than that of controls (201.31 ± 16.43 %), but not significantly. After the 
washout phase, the cells from TRPV4-/- mice decreased their volume significantly 
(### p<0.001), compared to the maximal volume after 20 minutes of hypotonic stress 
(Fig. 12B, 13) and the volume restoration during washout phase was the most substantial of 
all the groups. The difference in volume between Hypo20 and Wash20 was 77 % on average. 
In total, we measured the volume of 30 astrocytes from TRPV4-/- animals. The results 
obtained in TRPV4-/- mice were recently published in Pivonkova et al., 2018. 
Taken together, the volume of the cells lacking any of the channels of our interest did 
not differ significantly from the control group. We can summarize that swelling as well as 
volume restoration of astrocytes from AQP4-/-, TRPV4-/- and control mice during the 
hypotonic and washout phase were comparable.  
Figure 13: The average astrocyte volume reached after 20 minutes of hypotonic solution 
application. When compared to controls, none of the groups of cells from genetically modified 
animals showed any significant differences in their swelling. 
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8.2.4 Hypotonicity-induced volume changes of astrocytic endfeet 
In the second part of our experiments, we focused on the volume changes in astrocytic 
endfeet, because they are specialized structures surrounding brain capillaries and create a part 
of BBB. On the endfeet, a high density of AQP4 was shown (Nielsen et al., 1997; Furman et 
al., 2003), with possible colocalization with TRPV4 (Benfenati et al., 2011; Jo et al., 2015). 
We measured the diameter of endfeet in all our experimental groups and from the changes of 
the diameter we estimated changes of the endfeet volume. In total, we measured 52 astrocytic 
endfeet. For our experiments, we used the same protocol, as for the measurements of 
whole-cell volume (Fig. 11). 
In the endfeet of astrocytes from AQP4-/- animals (n = 24), we observed a significant 
volume increase in hypotonic conditions and also a significant volume decrease during the 
washout, when the cells were returned to aCSF. We did not find any difference between the 
average volume in controls and AQP4-/- - maximal volume of AQP4-/- was 155.72 ± 12.04 % 
and of controls was 149.89 ± 7.75 %. It is behavior very similar to the whole cells (Fig. 14A).  
Similarly, also astrocytic endfeet from TRPV4-/- animals (n = 12) changed their 
volume according to the applied solution. On the contrary to the rest of our results, we found 
a significant difference after 10 minutes of hypotonic solution application between the 
astrocytic endfeet volume from control (138.40 ± 5.58 %) and TRPV4-/- (120.60 ± 8.20 %; 
*p<0.05) mice (Fig. 14B, 15). But after 20 minutes of hypotonic conditions, the astrocytic 
endfeet volume of both goups was about the same. This suggests that the maximal volume 
increase evoked by hypotonic stress (after 20 min) is similar to that observed in controls, but 
slightly delayed within first 10 min in TRPV4-/- when compared to controls. These results 
were published in Pivonkova et al., 2018. 
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Figure 14: Hypotonicity-induced swelling of astrocytic endfeet. The light green parts represent 
hypotonic solution application, n represents the number of cells in each group. A) Astrocytic endfeet 
from AQP4-/- mice show an increase in their volume in hypotonic conditions and also a significant 
volume restoration during washout in aCSF (significance marks not shown). We did not observe any 
significant difference between the volume of astrocytic endfeet from AQP4-/- animals and those from 
controls. The astrocytic endfeet from TRPV4-/- mice showed a significantly smaller volume 
(*; p<0.05) after 10 min of hypotonic solution application when compared to controls, but in the other 
time points the volume ofastrocytic endfeet from TRPV4-/- and control animals did not differ (B). The 
astrocytic endfeet volume was estimated from stacks of focal images (Z-stacks) with a control 
measurement at the beginning (C) and another four measurements every 10 minutes during hypotonic 
solution application and washout (D, E). 
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Figure 15: Hypotonicity-induced swelling of astrocytic endfeet after 10 min of hypotonic solution 
application. We found a significant difference between the average volume increase of astrocytic 
endfeet from TRPV4-/- mice and from control mice (*; p<0.05). The astrocytic endfeet from AQP4-/- 
mice did not show any difference when compared to controls. 
8.2.5 OGD-induced astrocyte swelling 
OGD is a well-established model of reproducible ischemia. The cells (or in our case 
acute brain slices) are washed with a solution similar to aCSF, but without glucose, and the 
OGD solution is saturated with only 5% oxygen. For the experiments, we used the same 
experimental protocol, as in previous experiments with the hypotonic solution (Fig. 11).  
8.2.6 OGD-induced volume changes of astrocytes from AQP4-deficient animals 
The quantification of volume changes in situ during the OGD application revealed 
significant differences between astrocytes from AQP4-/- and control mice. The volume 
changes in astrocytes from AQP4-/- animals were in average significantly smaller (reaching 
108.75 ± 4.49 %; **p<0,01), while the average volume changes in controls were 153.99 ± 
12.94 % (Fig. 16A, 17). During the washout phase astrocytes of controls partially reduced 
their volume, while astrocytes from AQP4-/- mice did not decrease their volume, but they 
even started to rise. After 20 minutes of washout in aCSF, the cells from AQP4-/- animals 
reached a maximal volume change of 127.63 ± 12.72 %, which was similar to that detected in 
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controls (135.05 ± 9.72 %, Fig. 16A). In total, we quantified volume changes in 11 cells from 
AQP4-/- animals and 19 cells from control animals. 
8.2.7 OGD-induced volume changes of TRPV4-deficient astrocytes 
In TRPV4-/- astrocytes the volume changes evoked by 20 minutes of OGD were not 
significantly different from those observed in controls. During OGD the average volume 
changes in astrocytes from TRPV4-/- mice reached 135.75 ± 9.42 % (Fig. 16B) and 153.99 ± 
12.94 % in controls. Nevertheless, after 10 minutes of OGD we detected a slightly slower 
swelling in TRPV4-/- astrocyte (Fig. 17), however these changes were not significant. As both 
TRPV4-/- and control astrocyte showed similar volume changes during washout period, we 
can also conclude that TRPV4 deletion had no effect on astrocyte volume recovery. Astrocyte 
volume in both types of mice slowly declined during washout, reaching the average values of 
131.58 ± 9.47 % (TRPV4-/-) and 135.05 ± 9.72 % in controls (Fig. 16B). We quantified 
volume changes in 21 astrocytes from TRPV4-/- mice and the results were published by 
Pivonkova et al., 2018. 
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Figure 16: OGD-induced astrocyte volume changes. The light green parts represent OGD 
application. A) When compared to controls, the astrocytes from AQP4-/- mice showed a 
significantly smaller volume changes after OGD application (**p<0.01). They were also unable 
to restore their volume during the washout phase. On the contrary, the astrocytes from TRPV4-/- 
animals did not show any difference in their volume, when compared to controls (B). The 
astrocyte volume measurements followed a protocol with control measurement at the time 0 (C), 
which was followed by four measurements every 10 minutes during the OGD application and 
washout (D, E). 
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8.2.8 OGD-induced volume changes of astrocytic endfeet 
We measured diameter-based volume changes of astrocytic endfeet from AQP4-/-, 
TRPV4-/- and control animals. In total, we quantified volume chnages in 49 endfeet. For the 
measurements we used the same protocol as for all the other measurements (Fig. 11). 
Similarly to the whole astrocytes, astrocytic AQP4-/- endfeet showed a significantly 
smaller volume changes after 20 minutes of OGD application (maximal volume 119.60 ± 
5.61 %; *p<0.05), while marked volume changes were observed in endfeet of controls 
(150.60 ± %).  However, on the contrary to the whole cells, in AQP4-/- mice the volume of 
astrocytic endfeet was restored during the washout phase. The final volume was significantly 
smaller in AQP4-/- endfeet (102.95 ± %) than the volume of controls (148.78 ± %).  
Interestingly, The TRPV4-/- endfeet did not show any significant difference when 
compared to controls. They swelled during the OGD application and restored their volume 
during the washout, however just mildly and not significantly (Fig. 18B, 19). 
Figure 17: OGD-induced swelling of astrocytes after 20 min of OGD application. We found a 
significant difference between the average volume of astrocytes from AQP4-/- mice and from 
control mice (**p<0.01). The astrocytes from TRPV4-/- mice did not show any difference when 
compared to controls. 
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Figure 18: OGD-induced volume changes in astrocytic endfeet. The light green parts represent OGD 
application. A) When compared to controls, the astrocytic endfeet from AQP4-/- mice showed a 
significantly smaller volume changes after 20 min of OGD application (*p<0.05). They also restored their 
volume during the washout phase, contrary to controls (**p<0.01; ***p<0.001). The astrocytic endfeet 
from TRPV4-/- animals did not show any difference in their volume when compared to controls (B). The 
endfeet volume measurements followed a protocol with a control measurement at the time 0 (C), which 
was followed by a 20 min OGD application and 20 min washout (D, E). 
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Figure 19: OGD-induced volume changes of astrocytic endfeet after 20 minutes of OGD application. 
The astrocytic endfeet from AQP4-/- mice reached a significantly smaller volume (*p<0.05) than the 
controls. The astrocytic endfeet from TRPV4-/- animals did not differ from the controls. 
 
9 Discussion 
 
In this diploma theses, we investigated the role of AQP4 and TRPV4 in astrocytic 
volume changes evoked by ischemia like stimuli. Based on the results of previous in vitro 
experiments (Benfenati et al., 2011) we hypothesized that both AQP4 and TRPV4 could have 
a protective effect against cytotoxic brain swelling and that both channels could be involved 
in the process of astrocytic RVD. Our results indicate that different regulatory mechanisms 
are involved in our models because the responses of the astrocytes from our experimental 
groups differ between both pathological stimuli. 
9.1 Compensation of AQP4 deletion by changes in Connexin 43 localization 
AQP4 is a major form of water channels in the mouse brain. Its role in brain edema 
formation was studied in several projects using different models of ischemic injury (Manley 
et al., 2000; Papadopoulos and Verkman, 2005). These experiments confirmed better survival 
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of animals with induced ischemic injury and also the protective effect of AQP4 deletion on 
the size of brain edema.  
In our experiments, we were able to detect swelling of astrocytes from AQP4-/- 
animals during hypoosmotic stress. The fact, that AQP4-/- astrocytes swell to the same level 
as controls, was in opposition to our hypothesis as we supposed that removing the main water 
pathway from the astrocytic membranes would prevent the cells from swelling. The finding 
that they do increase their volume indicates involvement of some compensatory mechanism, 
which enables water to flow through the plasmatic membrane in approximately the same 
amount, as the AQP4 would. One of the possible and often suggested mechanisms is Cx43 
upregulation. Cx43 is astrocytic gap junctional protein, together with Cx30. These two 
proteins can be considered an intercellular pathways, through which water moves together 
with ions and small molecules. In the study of Katoozi et al., 2017, deletion of AQP4 led to a 
significant increase in the amount of Cx43. This increase, however, was caused by the 
changes in posttranslational modifications rather than the upregulation of Cx43 gene 
transcription. On the contrary, Nicchia et al., 2005 reported a decrease in the levels of Cx43 
associated with AQP4 gene silencing in vitro. These opposing findings can be the result of 
different regulatory mechanisms involved in cellular function in vitro and in vivo. Also in 
both experiments, different methods of AQP4 deletion were engaged.  
In favor of the involvement of Cx43 in the compensation of AQP4 deletion point also 
our results from the experiments with OGD. We used the OGD application on astrocytes to 
simulate properties of ischemic brain injury. Our experiments on AQP4-/- astrocytes revealed 
a significantly smaller volume of AQP4-/- astrocytes during OGD application, when 
compared to the controls. These findings are in agreement with the work of Anderova et al., 
2014, who performed in situ experiments with OGD application on 
α-syntrophin(α-Syn)-deficient animals and reported a significantly smaller volume of 
astrocytes from α-Syn-deficient animals. Similarly to our results, they did also not detect any 
volume decrease during the washout phase.  
Obviously, different regulatory mechanisms are involved in astrocytic volume 
changes induced by hypoosmotic stress and by OGD. The mechanisms, which were activated 
during the hypoosmotic stress to compensate AQP4 deletion are obviously not functioning 
during OGD. While the Cx43 can possibly contribute to hypotonicity-induced astrocyte 
swelling, during OGD it undergoes changes that result in the lack of swelling in the 
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astrocytes from AQP4-/- mice. Wu, Yu and Feng, 2015 and Xie et al., 2017 reported that 
during OGD Cx43 is retracted from the plasmatic membrane by endocytosis and translocated 
into the cytoplasm. This translocation together with AQP4 deletion can possibly result in the 
lack of pathways for water movement across the plasmatic membrane. It can also explain our 
results from AQP4-/- astrocytes and the fact, that the cells maintained approximately the same 
volume during the whole OGD application.  
In our experiments, during the washout phase after the OGD application astrocytes 
increased their volume. The lack of RVD during reoxygenation was previously reported in 
situ by Anderova et al., 2014. The finding that AQP4-/- astrocytes lack RVD and their volume 
continues to rise even in aCSF, can again be explained by the changes in Cx43 localization. 
In the study of Wu, Yu and Feng, 2015, a recovery of Cx43 localization on the plasmatic 
membrane was reported during reoxygenation after OGD. In our case, this would mean the 
opening of alternative pathways for water movement through plasmatic membranes and thus 
possibility of water influx into the astrocytes. After the Cx43 translocation back to the 
plasmatic membrane during the washout phase in our experiments, astrocyte volume 
continued to rise in agreement with the study of Anderova et al., 2014.  
On the contrary, our results showed a small volume increase of the astrocyte endfeet 
from AQP4-/- animals during OGD as well as a weak volume restoration during the following 
washout. According to the recent findings, astrocyte peripheral processes have their own 
local protein translation (Sakers et al., 2017). It is possible that this local translation is a key 
player in modulation of BBB and also in modulation of regulatory mechanisms that are 
engaged during the pathological treatment and which differ from the mechanisms activated in 
cell soma.  
9.2 Expression of TRPV4 channels in astrocytes 
We were not able to detect any volume differences between the whole astrocytes from 
TRPV4-/- and control animals under any of the pathological stimuli we used. Our ability to 
detect a significant volume decrease in TRPV4-/- astrocytes during washout is in contrast to 
the results from several in vitro studies. Those showed that suppression or deletion of TRPV4 
channels led to inhibition of RVD (Benfenati et al., 2011; Hoshi et al., 2018; Pivonkova et 
al., 2018). This difference can be caused by a low level of TRPV4 expression on astrocytes. 
Shibasaki et al., 2014 reported that only about 20 – 30 % of astrocytes do express TRPV4 
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channels in vitro and in situ. The same results were reported by Pivonkova et al., 2018, who 
measured TRPV4 presence in GFAP/EGFP astrocytes. Aside from the whole cells, we also 
measured diameter-based volume changes of astrocytic endfeet, where the TRPV4 is 
abundant (Benfenati et al., 2007). The only significant difference we dected between 
TRPV4-/- and control endfeet was after 10 min of hypotonic solution application when the 
TRPV4-/- endfeet reached a smaller volume than the controls. This can indicate involvement 
of TRPV4 channels in the speed of astrocytic volume kinetics.  
On the contrary to our own results, when we were not able to detect any significant 
difference between control and TRPV4-/- astrocytes, Chmelova et al., 2019 detected 
significantly smaller extracellular space (ECS) shrinkage in situ during OGD in TRPV4-/- 
animals than in controls. This is agreement with the results of Pivonkova et al., 2018, who 
found a significantly larger lesion after permanent MCAO in TRPV4-/- mice, than in controls. 
These findings indicate that TRPV4 channels have a protective function during ischemic 
brain injury, however, this function is probably not associated with astrocytes only.  
Since the TRPV4 channels alone do not trigger the RVD of astrocytes, they can affect 
astrocytic volume regulation via cooperation with other channels and transporters. These 
cooperations were suggested by several groups, the most often mentioned is with AQP4 
(Benfenati et al., 2011; Jo et al., 2015; Iuso and Križaj, 2016). 
9.3 Passive volume changes of cortical astrocyte 
Our results of hypotonic solution application on the astrocytes or astrocyte endfeet did 
not reveal any significant differences in between AQP4-/- and control animals. The same 
treatment with severe hypoosmotic stress used Anderova et al., 2014 on cortical astrocytes 
from α-Syn-deficient mice. α-Syn is a part of the dystrophin complex which anchors AQP4 to 
the specific locations on a plasmatic membrane, thus its deletion results in the removal of 
AQP4 from plasmatic membranes (Hoddevik et al., 2017). The results of Anderova et al., 
2014 indicate that deletion of α-Syn (and AQP4 removal) results in a significantly smaller 
volume increase of astrocytes during severe hypoosmotic stress when compared to controls. 
Because the hypoosmotic treatment was the same as we used, the difference in the results 
could be due to different data analysis. In the work of Anderova et al., 2014, a custom-made 
program was used for evaluating the astrocyte volume changes and they also used one month 
old animals. This may be the result for different outcomes. In our experiments, we quantified 
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the astrocyte volume based on fluorescence intensity using the ImageJ/FIJI software 
(Awadová et al., 2018).  
Same results of reduced cellular volume of AQP4-/- glia obtained also Iuso and Križaj, 
2016, but their measurements were performed on Müller glia in the retina and not on cortical 
astrocytes. It is possible that variable regulatory mechanisms are activated between these two 
glial types and that leads to different experimental results. On blood-retina interface, deletion 
of AQP4 leads to blood-retina barrier dysfunction and to astrocyte activation, which results in 
an inflammatory response of the retina (Nicchia et al., 2016). In our mice, however, no BBB 
impairment was detected. 
Based on the results of Benfenati et al., 2011, and Anderova et al., 2014, we did not 
expect to see any RVD in AQP4-/- and TRPV4-/- astrocytes during the washout phase in our 
experiments. However, our results from the experiments with hypotonic solution did show a 
significant volume decrease in the whole cells as well as in the astrocyte endfeet. The in vitro 
study of Benfenati et al., 2011 showed, that deletion of AQP4 led to stabilization of the 
increased volume reached during the hypoosmotic stimulation and that AQP4 together with 
TRPV4 are crucial in triggering astrocyte RVD. On the contrary, the in situ experiments of 
Anderova et al., 2014 revealed a mild volume reduction after long (90 min) washout even in 
control cells. These experiments used basically the same methods, as we did. Nevertheless, 
they did not detect any RVD. Interestingly, no RVD but also no difference in swelling of 
somata between AQP4-/- and control astrocytes occured after peri-infarct depolarization in 
vivo (Rakers, Schmid and Petzold, 2017). 
Our findings of immediate volume response to osmotic changes are in agreement with 
Risher, Andrew and Kirov, 2009. They suggested that osmotically-induced volume changes 
in astrocytes are passive and do not include any active processes, such as RVD. In that case, 
volume changes are a result of passive water flow through plasmatic membrane driven by 
osmotic gradients.  
Since astrocytes are the biggest population of glial cells in brain and are strongly 
involved in maintenance of brain homeostasis, any active volume regulations would possibly 
show not only on astrocytes themselves, but also on the changed parameters of ECS. 
Chmelova et al., 2019 measured ECS volume in mouse brain during severe hypoosmotic 
stress and found no difference between the ECS volume between AQP4-/- and control mice. 
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This finding contributes to the hypothesis, that the astrocyte volume changes occuring during 
hypoosmotic stress are passive. 
 
10 Conclusions 
 
In summary, our findings suggest that AQP4 deletion leads to an activation of 
compensatory mechanisms, which allow water transport through plasmatic membranes of 
astrocytes. We hypothesize that this compensation is accomplished by changes in Cx43 
posttranslational modifications, which result in an increased concentration of Cx43 channels 
on astrocytic membranes. On the contrary, the deletion of TRPV4 from astrocytes did not 
affect the swelling of astrocytes and we did not detect any changes that would indicate 
activation of any compensatory mechanisms. We therefore believe that TRPV4 might serve a 
protective effect during ischemic brain injury, however, this effect is probably not associated 
with astrocytes. Moreover, in our experiments we were unable to detect any active volume 
changes, such as RVD. Therefore we believe that volume changes of astrocytes induced by 
pathological stimuli are passive and that RVD is an attribute of cultured cells only.   
 
11 References 
 
Agre, P. et al. (2002) ‘Aquaporin water channels-from atomic structure to clinical medicine.’, 
The Journal of physiology, 542(Pt 1), pp. 3–16. doi: 10.1113/jphysiol.2002.020818. 
Agre, P. (2006) ‘The Aquaporin Water Channels’, Proceedings of the American Thoracic 
Society, 3, pp. 5–13. doi: 10.1513/pats.200510-109JH. 
Akdemir, G. et al. (2014) ‘Neuroprotective effect of aquaporin-4 deficiency in a mouse 
model of severe global cerebral ischemia produced by transient 4-vessel occlusion’, 
Neuroscience Letters, (547), pp. 70–75. doi: 10.1086/498510. 
 
54 
 
Alliot, F., Godin, I. and Pessac, B. (1999) ‘Microglia derive from progenitors, originating 
from the yolk sac, and which proliferate in the brain’, Developmental Brain Research, 
117(2), pp. 145–152. doi: 10.1016/S0165-3806(99)00113-3. 
Almeida, R. G. et al. (2011) ‘Individual axons regulate the myelinating potential of single 
oligodendrocytes in vivo’, Development, 138(20), pp. 4443–4450. doi: 10.1242/dev.071001. 
Anderova, M. et al. (2014) ‘Altered astrocytic swelling in the cortex of α-syntrophin-negative 
GFAP/EGFP MICE’, PLoS ONE, 9(11), pp. 1–34. doi: 10.1371/journal.pone.0113444. 
Anders, S. et al. (2014) ‘Spatial properties of astrocyte gap junction coupling in the rat 
hippocampus’, Philosophical Transactions of the Royal Society B: Biological Sciences, 
369(1654), pp. 20130600–20130600. doi: 10.1098/rstb.2013.0600. 
Armbruster, M., Hanson, E. and Dulla, C. G. (2016) ‘Glutamate Clearance Is Locally 
Modulated by Presynaptic Neuronal Activity in the Cerebral Cortex’, The Journal of 
Neuroscience, 36(40), pp. 10404–10415. doi: 10.1523/JNEUROSCI.2066-16.2016. 
Arniges, M. et al. (2006) ‘Human TRPV4 channel splice variants revealed a key role of 
ankyrin domains in multimerization and trafficking’, Journal of Biological Chemistry, 
281(3), pp. 1580–1586. doi: 10.1074/jbc.M511456200. 
Awadová, T. et al. (2018) ‘Cell volume changes as revealed by fluorescence microscopy: 
Global vs local approaches’, Journal of Neuroscience Methods, 306, pp. 38–44. 
doi: 10.1016/j.jneumeth.2018.05.026. 
Bacigaluppi, M., Comi, G. and Hermann, D. M. (2010) ‘Animal models of ischemic stroke. 
Part two: modeling cerebral ischemia.’, The open neurology journal, 4, pp. 34–38. 
doi: 10.2174/1874205X01004020034. 
Baethmann, A. (1978) ‘Pathophysiological and pathochemical aspects of cerebral edema’, 
Neurosurgical Review, 1, pp. 85–100. Available at: 
http://link.springer.com/article/10.1007/BF01646721. 
Becker, D. et al. (2008) ‘The C-terminal domain of TRPV4 is essential for plasma membrane 
localization’, Molecular Membrane Biology, 25(2), pp. 139–151. 
doi: 10.1080/09687680701635237. 
 
55 
 
De Bellis, M. et al. (2017) ‘Translational readthrough generates new astrocyte AQP4 
isoforms that modulate supramolecular clustering, glial endfeet localization, and water 
transport’, Glia, 65(5), pp. 790–803. doi: 10.1002/glia.23126. 
Benfenati, V. et al. (2007) ‘Expression and functional characterization of transient receptor 
potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes’, Neuroscience, 
148(4), pp. 876–892. doi: 10.1016/j.neuroscience.2007.06.039. 
Benfenati, V. et al. (2011) ‘An aquaporin-4/transient receptor potential vanilloid 4 
(AQP4/TRPV4) complex is essential for cell-volume control in astrocytes.’, Proceedings of 
the National Academy of Sciences of the United States of America, 108(6), pp. 2563–2568. 
doi: 10.1073/pnas.1012867108. 
Berdichevsky, E. et al. (1983) ‘Kainate, N-methylaspartate and other excitatory amino acids 
increase calcium influx into rat brain cortex cells in vitro’, Neuroscience Letters, 36(1), pp. 
75–80. doi: 10.1016/0304-3940(83)90489-5. 
Brambilla, R. et al. (2009) ‘Transgenic inhibition of astroglial NF-κB leads to increased 
axonal sparing and sprouting following spinal cord injury’, The Journal of Neurochemistry, 
110(2), pp. 765–778. doi: 10.1111/j.1471-4159.2009.06190.x.Transgenic. 
Busch, E. et al. (1996) ‘Potassium-induced cortical spreading depressions during focal 
cerebral ischemia in rats: Contribution to lesion growth assessed by diffusion-weighted NMR 
and biochemical imaging’, Journal of Cerebral Blood Flow and Metabolism, 16(6), pp. 
1090–1099. doi: 10.1097/00004647-199611000-00002. 
Butenko, O. et al. (2012) ‘The increased activity of TRPV4 channel in the astrocytes of the 
adult rat hippocampus after cerebral Hypoxia/Ischemia’, PLoS ONE, 7(6), p. e39959. 
doi: 10.1371/journal.pone.0039959. 
Cahoy, J. D. et al. (2008) ‘A Transcriptome Database for Astrocytes , Neurons , and 
Oligodendrocytes : A New Resource for Understanding Brain Development and Function’, 
28(1), pp. 264–278. doi: 10.1523/JNEUROSCI.4178-07.2008. 
Camassa, L. M. A. et al. (2015) ‘Mechanisms underlying AQP4 accumulation in astrocyte 
endfeet’, Glia, 63(11), pp. 2073–2091. doi: 10.1002/glia.22878. 
 
56 
 
Carloni, S. et al. (2007) ‘Extended role of necrotic cell death after hypoxia-ischemia-induced 
neurodegeneration in the neonatal rat’, Neurobiology of Disease, 27(3), pp. 354–361. 
doi: 10.1016/j.nbd.2007.06.009. 
Cheng, Y. et al. (1998) ‘Caspase inhibitor affords neuroprotection with delayed 
administration in a rat model of neonatal hypoxic-ischemic brain injury’, Journal of Clinical 
Investigation, 101(9), pp. 1992–1999. doi: 10.1172/JCI2169. 
Chmelova, M. et al. (2019) ‘The role of aquaporin-4 and transient receptor potential vaniloid 
isoform 4 channels in the development of cytotoxic edema and associated extracellular 
diffusion parameter changes’, European Journal of Neuroscience, (Jan 11). 
doi: 10.1111/ejn.14338. 
Choi, D. W. (1988) ‘Glutamate neurotoxicity and diseases of the nervous system’, Neuron, 
1(8), pp. 623–634. doi: 10.1016/0896-6273(88)90162-6. 
Chvátal, A., Anděrová, M. and Kirchhoff, F. (2007) ‘Three-dimensional confocal 
morphometry – a new approach for studying dynamic changes in cell morphology in brain 
slices’, Journal of Anatomy, 210(6), pp. 671–683. doi: 10.1111/j.1469-7580.2007.00724.x. 
Clapham, D. E., Runnels, L. W. and Strübing, C. (2001) ‘The TRP ion channel family’, 
Nature Reviews Neuroscience, 2(6), pp. 387–396. doi: 10.1038/35077544. 
Cornell-Bell, A. H. et al. (1990) ‘Glutamate induces calcium waves in cultured astrocytes: 
long- range glial signalling’, Science, 247(4941), pp. 470–473. PMID: 1967852. 
Dawson, M. R. L. et al. (2003) ‘NG2-expressing glial progenitor cells: An abundant and 
widespread population of cycling cells in the adult rat CNS’, Molecular and Cellular 
Neuroscience, 24(2), pp. 476–488. doi: 10.1016/S1044-7431(03)00210-0. 
Deng, Z. et al. (2018) ‘Cryo-EM and X-ray structures of TRPV4 reveal insight into ion 
permeation and gating mechanisms’, Nature Structural and Molecular Biology, 25(3), pp. 
252–260. doi: 10.1038/s41594-018-0037-5.Cryo-EM. 
Dijkhuizen, R. M. et al. (1999) ‘Correlation between tissue depolarizations and damage in 
focal ischemic rat brain’, Brain Research, 840(1–2), pp. 194–205. doi: 10.1016/S0006-
8993(99)01769-2. 
 
57 
 
Dunn, K. M. et al. (2013) ‘TRPV4 channels stimulate Ca2+-induced Ca2+ release in 
astrocytic endfeet and amplify neurovascular coupling responses’, Proceedings of the 
National Academy of Sciences, 110(15), pp. 6157–6162. doi: 10.1073/pnas.1216514110. 
Durukan, A. and Tatlisumak, T. (2007) ‘Acute ischemic stroke: Overview of major 
experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia’, 
Pharmacology Biochemistry and Behavior, 87(1), pp. 179–197. 
doi: 10.1016/j.pbb.2007.04.015. 
Fan, Y. et al. (2013) ‘Aquaporin-4 promotes memory consolidation in Morris water maze’, 
Brain Structure and Function, 218(1), pp. 39–50. doi: 10.1007/s00429-011-0373-2. 
Faulkner, J. R. et al. (2004) ‘Reactive Astrocytes Protect Tissue and Preserve Function after 
Spinal Cord Injury’, Journal of Neuroscience, 24(9), pp. 2143–2155. 
doi: 10.1523/JNEUROSCI.3547-03.2004. 
Feetham, C. H. et al. (2015) ‘TRPV4 and KCa ion channels functionally couple as 
osmosensors in the paraventricular nucleus’, British Journal of Pharmacology, 172(7), pp. 
1753–1768. doi: 10.1111/bph.13023. 
Fenske, A. R. and Prioleau, G. R. (1978) ‘Clearance of edema fluid into cerebrospinal fluid’, 
J Neurosurg, 48, pp. 754–764. doi: 10.3171/jns.1978.48.5.0754. 
Fishman, R. A. (1975) ‘Brain edema’, The New England journal of medicine, 239(14), pp. 
706–711. doi: 10.1056/NEJM197510022931407. 
Fluri, F., Schuhmann, M. K. and Kleinschnitz, C. (2015) ‘Animal models of ischemic stroke 
and their application in clinical research’, Drug Design, Development and Therapy, 9, pp. 
3445–3454. doi: 10.2147/DDDT.S56071. 
Furman, C. S. et al. (2003) ‘Aquaporin-4 square array assembly: opposing actions of M1 and 
M23 isoforms.’, Proceedings of the National Academy of Sciences of the United States of 
America, 100(23), pp. 13609–13614. doi: 10.1073/pnas.2235843100. 
Garcia-Elias, A. et al. (2013) ‘Phosphatidylinositol-4,5-biphosphate-dependent 
rearrangement of TRPV4 cytosolic tails enables channel activation by physiological stimuli’, 
Proceedings of the National Academy of Sciences, 110(23), pp. 9553–9558. 
doi: 10.1073/pnas.1220231110. 
58 
 
Ginhoux, F. et al. (2010) ‘Fate Mapping Analysis Reveals That Adult Microglia Derive from 
Primitive Macrophages’, Science, 330(6005), pp. 841–845. 
doi: 10.1126/science.1194637.Fate. 
Giulian, D. and Baker, T. I. (1985) ‘Peptides released by ameboid microglia regulate 
astroglial proliferation’, Journal of Cell Biology, 101(6), pp. 2411–2415. 
doi: 10.1083/jcb.101.6.2411. 
Güler, A. D. et al. (2002) ‘Heat-Evoked Activation of the Ion Channel, TRPV4’, Journal of 
Neuroscience, 22(15), pp. 6408–6414. doi: 20026679. 
Harraz, O. F. et al. (2018) ‘PIP2 depletion promotes TRPV4 channel activity in mouse brain 
capillary endothelial cells’, eLife, 7(c), pp. 1–4. doi: 10.7554/eLife.38689. 
Hatashita, S., Hoff, J. T. and Salamat, S. M. (1988) ‘Ischemic brain edema and the osmotic 
gradient between blood and brain’, Journal of Cerebral Blood Flow and Metabolism, pp. 
552–559. doi: 10.1038/jcbfm.1988.96. 
Herculano-Houzel, S. (2014) ‘The glia/neuron ratio: How it varies uniformly across brain 
structures and species and what that means for brain physiology and evolution’, Glia, 62(9), 
pp. 1377–1391. doi: 10.1002/glia.22683. 
Hirt, L. et al. (2016) ‘Improved long-term outcome after transient cerebral ischemia in 
aquaporin-4 knockout mice.’, Journal of cerebral blood flow and metabolism : official 
journal of the International Society of Cerebral Blood Flow and Metabolism, pp. 1–14. doi: 
10.1177/0271678X15623290. 
Hoddevik, E. H. et al. (2017) ‘Factors determining the density of AQP4 water channel 
molecules at the brain–blood interface’, Brain Structure and Function, 222(4), pp. 
1753-1766. doi: 10.1007/s00429-016-1305-y. 
Honsa, P. et al. (2016) ‘Generation of reactive astrocytes from NG2 cells is regulated by 
sonic hedgehog’, Glia, 64(9), pp. 1518–1531. doi: 10.1002/glia.23019. 
Hoshi, Y. et al. (2018) ‘Ischemic Brain Injury Leads to Brain Edema via Hyperthermia-
Induced TRPV4 Activation’, Journal of Neuroscience, 38(25), pp. 5700–5709. 
doi: 10.1523/JNEUROSCI.2888-17.2018. 
 
59 
 
Huang, W. et al. (2014) ‘Novel NG2-CreERT2 knock-in mice demonstrate heterogeneous 
differentiation potential of NG2 glia during development’, Glia, 62(6), pp. 896–913. 
doi: 10.1002/glia.22648. 
Ikeshima-kataoka, H. et al. (2013) ‘Molecular and Cellular Neuroscience Immunological 
function of aquaporin-4 in stab-wounded mouse brain in concert with a pro-in fl ammatory 
cytokine inducer , osteopontin’, Molecular and Cellular Neuroscience. Elsevier Inc., 56, pp. 
65–75. doi: 10.1016/j.mcn.2013.02.002. 
Iuso, A. and Križaj, D. (2016) ‘TRPV4-AQP4 interactions “turbocharge” astroglial 
sensitivity to small osmotic gradients’, Channels. Taylor & Francis, 10(3), pp. 172–174. 
doi: 10.1080/19336950.2016.1140956. 
Jessen, K. R. (2004) ‘Glial cells’, International Journal of Biochemistry and Cell Biology, 
36(10), pp. 1861–1867. doi: 10.1016/j.biocel.2004.02.023. 
Jeuregui-Huerta, F. et al. (2010) ‘Responses of glial cells to stress and glucocorticoids’, 
Current Immunology Review, 6(3), pp. 195–204. 
doi: 10.2174/157339510791823790.Responses. 
Jie, P. et al. (2015) ‘Activation of transient receptor potential vanilloid 4 induces apoptosis in 
hippocampus through downregulating PI3K/Akt and upregulating p38 MAPK signaling 
pathways’, Cell Death and Disease, 6(6), p. e1775. doi: 10.1038/cddis.2015.146. 
Jie, P. et al. (2015) ‘Blockage of transient receptor potential vanilloid 4 inhibits brain edema 
in middle cerebral artery occlusion mice’, Frontiers in Cellular Neuroscience, 9(April), pp. 
1–6. doi: 10.3389/fncel.2015.00141. 
Jo, A. O. et al. (2015) ‘TRPV4 and AQP4 Channels Synergistically Regulate Cell Volume 
and Calcium Homeostasis in Retinal Műller Glia’, Journal of Neuroscience, 35(39), pp. 
13525–13537. doi: 10.1523/JNEUROSCI.1987-15.2015. 
Kaneko, D., Nakamura, N. and Ogawa, T. (1985) ‘Cerebral infarction in rats using 
homologous blood emboli: development of a new experimental model’, Stroke, 16(1), pp. 
76–84. doi: 10.1161/01.STR.16.1.76. 
 
 
60 
 
Kang, S. H. et al. (2010) ‘NG2+ CNS glial progenitors remain committed to the 
oligodendrocyte lineage in postnatal life and following neurodegeneration’, Neuron, 68(4), 
pp. 668–681. doi: 10.1016/j.neuron.2010.09.009.NG2. 
Kanju, P. and Liedtke, W. (2016) ‘Pleiotropic function of TRPV4 ion channels in the central 
nervous system’, Experimental Physiology, 101(12), pp. 1472–1476. doi: 10.1113/EP085790. 
Katada, R. et al. (2014) ‘Greatly improved survival and neuroprotection in aquaporin-4-
knockout mice following global cerebral ischemia’, FASEB Journal, 28(2), pp. 705–714. doi: 
10.1096/fj.13-231274. 
Katoozi, S. et al. (2017) ‘Targeted deletion of Aqp4 promotes the formation of astrocytic gap 
junctions’, Brain Structure and Function, 222(9), pp. 3959–3972. doi: 10.1007/s00429-017-
1448-5. 
Kenny, A., Plank, M. J. and David, T. (2018) ‘The role of astrocytic calcium and TRPV4 
channels in neurovascular coupling’, Journal of Computational Neuroscience, 44(1), pp. 97–
114. doi: 10.1007/s10827-017-0671-7. 
Kitchen, P. et al. (2016) ‘Structural determinants of oligomerization of the aquaporin-4 
channel’, Journal of Biological Chemistry, 291(13), pp. 6858–6871. doi: 
10.1074/jbc.M115.694729. 
Klatzo, I. (1987) ‘Pathophysiological aspects of brain edema’, Acta Neuropathologica, 72, 
pp. 236–239. doi: 10.1016/0303-8467(84)90069-6. 
Klatzo, I. (1994) ‘Evolution of brain edema concepts’, Acta Neurochirurgica Supplement 
(Wien), 60, pp. 3–6. PMID: 7976571. 
Knot, H. J., Zimmermann, P. A. and Nelson, M. T. (1996) ‘Extracellular K+-induced 
hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward 
rectifier K+ channels’, Journal of Physiology, 492(2), pp. 419–430. doi: 
10.1113/jphysiol.1996.sp021318. 
Kondo, T. and Raff, M. C. (2000) ‘Oligodendrocyte precursor cells reprogrammed to become 
multipotent stem cells’, Science, 289(September 2000), pp. 1754–1757. doi: 
10.1126/science.289.5485.1754. 
 
61 
 
Kong, H. et al. (2014) ‘Aquaporin-4 Knockout Exacerbates Corticosterone-Induced 
Depression by Inhibiting Astrocyte Function and Hippocampal Neurogenesis’, CNS 
Neuroscience and Therapeutics, 20(5), pp. 391–402. doi: 10.1111/cns.12222. 
Krupenko, S. A. (2009) ‘FDH: an Aldehyde Dehydrogenase Fusion Enzyme in Folate 
Metabolism’, Chemico-Biological Interactions, 178(1–3), pp. 84–93. doi: 
10.1016/j.cbi.2008.09.007.FDH. 
Lafrenaye, A. D. and Simard, J. M. (2019) ‘Bursting at the Seams : Molecular Mechanisms 
Mediating Astrocyte Swelling’, International Journal of Molecular Sciences, 20, p. 330. doi: 
10.3390/ijms20020330. 
Le, H. T. et al. (2014) ‘Gap junction intercellular communication mediated by connexin43 in 
astrocytes is essential for their resistance to oxidative stress’, Journal of Biological 
Chemistry, 289(3), pp. 1345–1354. doi: 10.1074/jbc.M113.508390. 
Lennon, V. A. et al. (2005) ‘IgG marker of optic-spinal multiple sclerosis binds to the 
aquaporin-4 water channel’, The Journal of Experimental Medicine, 202(4), pp. 473–477. 
doi: 10.1084/jem.20050304. 
Liddelow, S. A. et al. (2017) ‘Neurotoxic reactive astrocytes are induced by activated 
microglia’, Nature, 541(7638), pp. 481–487. doi: 10.1038/nature21029.Neurotoxic. 
Liedtke, W. and Friedman, J. M. (2003) ‘Abnormal osmotic regulation in trpv4-/-  mice’, 
Proceedings of the National Academy of Sciences of the United States of America, 100(23), 
pp. 13698–13703. doi: 10.1073/pnas.1735416100. 
Linnik, M. D. et al. (1993) ‘Evidence supporting a role for programmed cell death in focal 
cerebral ischemia in rats’, Stroke, 24(ischemia, apoptosis), pp. 2002–2009. PMID: 8248983. 
Lipski, J. et al. (2006) ‘Involvement of TRP-like channels in the acute ischemic response of 
hippocampal CA1 neurons in brain slices’, Brain Research, 1077(1), pp. 187–199. doi: 
10.1016/j.brainres.2006.01.016. 
Lisjak, M. et al. (2017) ‘AQP4e-based orthogonal arrays regulate rapid cell volume changes 
in astrocytes.’, Journal of Neuroscience, c, pp. 0776-17. doi: 10.1523/JNEUROSCI.0776-
17.2017. 
 
62 
 
Liu, F. and McCullough, L. D. (2011) ‘Middle cerebral artery occlusion model in rodents: 
Methods and potential pitfalls’, Journal of Biomedicine and Biotechnology, 2011. doi: 
10.1155/2011/464701. 
Liu, M. et al. (2018) ‘TRPV4 Inhibition Improved Myelination and Reduced Glia Reactivity 
and Inflammation in a Cuprizone-Induced Mouse Model of Demyelination’, Frontiers in 
Cellular Neuroscience, 12(November), pp. 1–12. doi: 10.3389/fncel.2018.00392. 
Liu, X. et al. (2008) ‘Lack of sex-linked differences in cerebral edema and aquaporin-4 
expression after experimental stroke’, Journal of Cerebral Blood Flow and Metabolism, 
28(12), pp. 1898–1906. doi: 10.1038/jcbfm.2008.83.Lack. 
Liu, Y. et al. (2002) ‘Oligodendrocyte and astrocyte development in rodents: An in situ and 
immunohistological analysis during embryonic development’, Glia, 40(1), pp. 25–43. doi: 
10.1002/glia.10111. 
Maglione, M. et al. (2010) ‘Oligodendrocytes in mouse corpus callosum are coupled via gap 
junction channels formed by Connexin47 and Connexin32’, Glia, 58(9), pp. 1104–1117. doi: 
10.1002/glia.20991. 
Magnotti, L. M., Goodenough, D. a and Paul, D. L. (2011) ‘Functional Heterotypic 
Interactions Between Astrocyte and Oligodendrocyte Connexins’, Glia, 59(1), pp. 26–34. 
doi: 10.1002/glia.21073.Functional. 
Manley, G. T. et al. (2000) ‘Aquaporin-4 deletion in mice reduces brain edema after acute 
water intoxication and ischemic stroke.’, Nature medicine, 6(2), pp. 159–163. doi: 
10.1038/72256. 
Manley, G. T. et al. (2004) ‘New insights into water transport and edema in the central 
nervous system from phenotype analysis of aquaporin-4 null mice’, Neuroscience, 129(4), 
pp. 983–991. doi: 10.1016/j.neuroscience.2004.06.088. 
McBean, D. E. and Kelly, P. A. T. (1998) ‘Rodent models of global cerebral ischemia: A 
comparison of two-vessel occlusion and four-vessel occlusion’, General Pharmacology, 
30(4), pp. 431–434. doi: 10.1016/S0306-3623(97)00284-X. 
 
 
63 
 
Mensch, S. et al. (2015) ‘Synaptic vesicle release regulates the number of myelin sheaths 
made by individual oligodendrocytes in vivo’, Nature neuroscience, 18(5), pp. 628–630. doi: 
10.1038/nn.3991.Synaptic. 
Mies, G., Iijima, T. and Hossmann, K. A. (1993) ‘Correlation between Peri-infarct DC Shifts 
and Ischaemic Neuronal Damage in Rat’, NeuroReport, 4, pp. 709–7011. doi: 
10.1097/00001756-199306000-00027. 
Miller, R. H. and Raff, M. C. (1984) ‘Fibrous and protoplasmic astrocytes are biochemically 
and developmentally distinct’, The Journal of Neuroscience, 4(2), pp. 585–592. doi: 
https://doi.org/10.1523/JNEUROSCI.04-02-00585.1984 
Mola, M. G. et al. (2017) ‘The Speed of Swelling Kinetics Modulates Cell Volume 
Regulation and Calcium Signaling in Astrocytes: A Different Point of View on the Role of 
Aquaporins’, Glia, 64(1), pp. 139–154. doi: 10.1002/glia.22921.The. 
Morales-Mulia, S. et al. (1998) ‘Osmotic swelling-induced changes in cytosolic calcium do 
not affect regulatory volume decrease in rat cultured suspended cerebellar astrocytes.’, 
Journal of Neurochemistry, 71, pp. 2330–2338. doi: 10.1046/j.1471-4159.1998.71062330.x 
Morizawa, Y. M. et al. (2017) ‘Reactive astrocytes function as phagocytes after brain 
ischemia via ABCA1-mediated pathway’, Nature Communications, 8(1). doi: 
10.1038/s41467-017-00037-1. 
Mulligan, S. J. and MacVicar, B. A. (2004) ‘Calcium transients in astrocyte endfeet cause 
cerebrovascular constrictions’, Nature, 431(7005), pp. 195–199. doi: 10.1038/nature02827. 
Nakajima, K. et al. (2001) ‘Neurotrophin secretion from cultured microglia’, Journal of 
Neuroscience Research, 65(4), pp. 322–331. doi: 10.1002/jnr.1157. 
Neely, J. D. et al. (1999) ‘Heterotetrameric composition of aquaporin-4 water channels’, 
Biochemistry, 38(34), pp. 11156–11163. doi: 10.1021/bi990941s. 
Neely, J. D. et al. (2001) ‘Syntrophin-dependent expression and localization of Aquaporin-4 
water channel protein’, Proceedings of the National Academy of Sciences of the United States 
of America, 98(24), pp. 14108–14113. doi: 10.1073/pnas.241508198. 
 
64 
 
Nicchia, G. P. et al. (2005) ‘New possible roles for aquaporin-4 in astrocytes: cell 
cytoskeleton and functional relationship with connexin43’, The FASEB Journal, 19(12), pp. 
1674–1676. doi: 10.1096/fj.04-3281fje. 
Nicchia, G. P. et al. (2010) ‘Higher order structure of aquaporin-4’, Neuroscience. Elsevier 
Inc., 168(4), pp. 903–914. doi: 10.1016/j.neuroscience.2010.02.008. 
Nicchia, G. P. et al. (2016) ‘Glio-vascular modifications caused by Aquaporin-4 deletion in 
the mouse retina’, Experimental Eye Research. Elsevier Ltd, 146, pp. 259–268. doi: 
10.1016/j.exer.2016.03.019. 
Nielsen, S. et al. (1997) ‘Specialized membrane domains for water transport in glial cells: 
high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.’, The Journal of 
Neuroscience, 17(1), pp. 171–180. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/8987746. 
Nilius, B. and Voets, T. (2013) ‘The puzzle of TRPV4 channelopathies’, EMBO Reports. 
Nature Publishing Group, 14(2), pp. 152–163. doi: 10.1038/embor.2012.219. 
Nimmerjahn, A., Kirchhoff, F. and Helmchen, F. (2005) ‘Neuroscience: Resting microglial 
cells are highly dynamic surveillants of brain parenchyma in vivo’, Science, 308(5726), pp. 
1314–1318. doi: 10.1126/science.1110647. 
Nolte, C. et al. (1996) ‘Complement 5a controls motility of murine microglial cells in vitro 
via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton’, 
Neuroscience, 73(4), pp. 1091–1107. doi: 10.1016/0306-4522(96)00106-6. 
Nolte, C. et al. (2001) ‘GFAP Promoter-Controlled EGFP- Expressing Transgenic Mice : A 
Tool to Visualize Astrocytes and Astrogliosis in Living Brain Tissue’, Glia, 33, pp. 72–86. 
doi: 10.1002/1098-1136(20010101)33:1<72::AID-GLIA1007>3.0.CO%3B2-A. 
Northington, F. J. et al. (2001) ‘Early neurodegeneration after hypoxia-ischemia in neonatal 
rat is necrosis while delayed neuronal death is apoptosis’, Neurobiology of Disease, 8(2), pp. 
207–219. doi: 10.1006/nbdi.2000.0371. 
Northington, F. J., Chavez-Valdez, R. and Martin, L. J. (2011) ‘Neuronal Cell Death in 
Neonatal Hypoxia-Ischemia’, Annals of Neurology, 69(5), pp. 743–758. doi: 
10.1002/ana.22419.Neuronal. 
65 
 
Oberheim, N. A. et al. (2010) ‘Uniquely hominid features of adult human astrocytes’, 
Journal of Neurophysiology, 29(10), p. 3276. doi: 10.1523/JNEUROSCI.4707-
08.2009.Uniquely. 
Ohashi, K. et al. (2018) ‘TRPV4 is functionally expressed in oligodendrocyte precursor cells 
and increases their proliferation’, Pflugers Archiv European Journal of Physiology, 470(5), 
pp. 705–716. doi: 10.1007/s00424-018-2130-3. 
Olney, J. W. et al. (1986) ‘The role of specific ions in glutamate neurotoxicity’, Neuroscience 
Letters, 65(1), pp. 65–71. doi: 10.1016/0304-3940(86)90121-7. 
Olney, J. W., Ho, O. L. and Rhee, V. (1971) ‘Cytotoxic effects of acidic and sulphur 
containing amino acids on the infant mouse central nervous system’, Experimental Brain 
Research, 14(1), pp. 61–76. doi: 10.1007/BF00234911. 
Papadopoulos, M. C. and Verkman, A. S. (2005) ‘Aquaporin-4 gene disruption in mice 
reduces brain swelling and mortality in pneumococcal meningitis’, Journal of Biological 
Chemistry, 280(14), pp. 13906–13912. doi: 10.1074/jbc.M413627200. 
Papadopoulos, M. C. and Verkman, A. S. (2013) ‘Aquaporin water channels in the nervous 
system’, Nature Reviews Neuroscience, 14(4), pp. 265–277. doi: 10.1038/nrn3468. 
Parakalan, R. et al. (2012) ‘Transcriptome analysis of amoeboid and ramified microglia 
isolated from the corpus callosum of rat brain’, BMC Neuroscience, 13(1), p. 1. doi: 
10.1186/1471-2202-13-64. 
Parkhurst, C. N. et al. (2014) ‘Microglia promote learning-dependent synapse formation 
through BDNF’, Cell, 155(7), pp. 1596–1609. doi: 10.1016/j.cell.2013.11.030.Microglia. 
Pascual, O. et al. (2012) ‘Microglia activation triggers astrocyte-mediated modulation of 
excitatory neurotransmission’, Proceedings of the National Academy of Sciences of the 
United States of America, 109(4), pp. E197–E205. doi: 10.1073/pnas.1111098109. 
Pivonkova, H. et al. (2018) ‘The Contribution of TRPV4 Channels to Astrocyte Volume 
Regulation 4 and Brain Edema Formation’, Neuroscience, 394, pp. 127–143. doi: 
10.1016/j.neuroscience.2018.10.028. 
 
66 
 
Preston, G. M. et al. (1992) ‘Appearance of Water Channels in Xenopus Oocytes Expressing 
Red Cell CHIP28 Protein’, Science, 256(5055), pp. 385–387. doi: 
10.1126/science.256.5055.385. 
Rakers, C., Schmid, M. and Petzold, G. C. (2017) ‘TRPV4 channels contribute to calcium 
transients in astrocytes and neurons during peri-infarct depolarizations in a stroke model’, 
Glia, 65(9), pp. 1550–1561. doi: 10.1002/glia.23183. 
Ransom, B. R. and Blank, W. F. (1975) ‘The pathology of cerebral edema’, Human 
Pathology, 6(5), pp. 642–643. doi: 10.1016/S0046-8177(75)80054-2. 
Rash, J. E. et al. (1998) ‘Direct immunogold labeling of aquaporin-4 in square arrays of 
astrocyte and ependymocyte plasma membranes in rat brain and spinal cord.’, Proceedings of 
the National Academy of Sciences of the United States of America, 95(20), pp. 11981–11986. 
doi: 10.1073/pnas.95.20.11981. 
Risher, W. C., Andrew, R. D. and Kirov, S. A. (2009) ‘Real-Time Passive Volume Responses 
of Astrocytes to Acute Osmotic and Ischemic Stress in Cortical Slices and in vivo Revealed 
by Two-Photon Microscopy’, Glia, 57(2), pp. 207–221. doi: 10.1002/glia.20747.Real-Time. 
Rosenberg, G. A. (1999) ‘Ischemic brain edema’, Progress in Cardiovascular Diseases, 
42(3), pp. 209–216. doi: 10.1016/S0033-0620(99)70003-4. 
Rossi, D. J., Oshima, T. and Attwell, D. (2000) ‘Glutamate release in severe brain ischaemia 
is mainly by reversed uptake’, Nature, 403(6767), pp. 316–321. doi: 10.1038/35002090. 
Saadoun, S. et al. (2005) ‘Involvement of aquaporin-4 in astroglial cell migration and glial 
scar formation’, Journal of Cell Science, 118(24), pp. 5691–5698. doi: 10.1242/jcs.02680. 
Sakers, K. et al. (2017) ‘Astrocytes locally translate transcripts in their peripheral processes’, 
Proceedings of the National Academy of Sciences of the United States of America, 114(19), 
pp. E3830–E3838. doi: 10.1073/pnas.1617782114. 
Schuier, F. J. and Hossmann, K.-A. (1980) ‘Experimental Brain Infarcts in Cats: II. Ischemic 
Brain Edema’, Stroke, 11(6), pp. 593–601. 
 
 
67 
 
Shibasaki, K. et al. (2014) ‘A novel subtype of astrocytes expressing TRPV4 (Transient 
Receptor Potential Vanilloid 4) Regulates neuronal excitability via release of 
gliotransmitters’, Journal of Biological Chemistry, 289(21), pp. 14470–14480. doi: 
10.1074/jbc.M114.557132. 
Shigematsu, H. et al. (2010) ‘A 3.5-nm structure of rat TRPV4 cation channel revealed by 
zernike phase-contrast cryoelectron microscopy’, Journal of Biological Chemistry, 285(15), 
pp. 11210–11218. doi: 10.1074/jbc.M109.090712. 
Smith, A. J. and Verkman, A. S. (2015) ‘Superresolution Imaging of Aquaporin-4 Cluster 
Size in Antibody-Stained Paraffin Brain Sections’, Biophysical Journal, 109(12), pp. 2511–
2522. doi: 10.1016/j.bpj.2015.10.047. 
Sofroniew, M. V. and Vinters, H. V. (2010) ‘Astrocytes: Biology and pathology’, Acta 
Neuropathologica, 119(1), pp. 7–35. doi: 10.1007/s00401-009-0619-8. 
Sorbo, J. G. et al. (2008) ‘The molecular composition of square arrays’, Biochemistry, 47(8), 
pp. 2631–2637. doi: 10.1021/bi702146k. 
Stelter, R. A. et al. (2014) ‘Preconditioning Provides Neuroprotection in Models of CNS 
Disease: Paradigms and Clinical Significance’, Progress in Neurobiology, 0, pp. 58–83. doi: 
10.1016/j.pneurobio.2013.11.005.Preconditioning. 
Tait, M. J. et al. (2008) ‘Water movements in the brain: role of aquaporins’, Trends in 
Neurosciences, 31(1), pp. 37–43. doi: 10.1016/j.tins.2007.11.003. 
Takano, T. et al. (2006) ‘Astrocyte-mediated control of cerebral blood flow’, Nature 
Neuroscience, 9(2), pp. 260–267. doi: 10.1038/nn1623. 
Tang, Y. et al. (2010) ‘Effects of Aquaporin-4 on edema formation following intracerebral 
hemorrhage’, Experimental Neurology. Elsevier Inc., 223(2), pp. 485–495. doi: 
10.1016/j.expneurol.2010.01.015. 
Tasca, C. I., Dal-Cim, T. and Cimarosti, H. (2015) ‘In Vitro Oxygen-Glucose Deprivation to 
Study Ischemic Cell Death’, Methods in Molecular Biology, 1254, pp. 197–210. doi: 
10.1007/978-1-4939-2152-2_15. 
 
68 
 
Thomsen, R. et al. (2013) ‘Alternative mRNA Splicing from the Glial Fibrillary Acidic 
Protein (GFAP) Gene Generates Isoforms with Distinct Subcellular mRNA Localization 
Patterns in Astrocytes’, PLoS ONE, 8(8). doi: 10.1371/journal.pone.0072110. 
Tornabene, E. and Brodin, B. (2016) ‘Stroke and Drug Delivery - In Vitro Models of the 
Ischemic Blood-Brain Barrier’, Journal of Pharmaceutical Sciences. Elsevier Ltd, 105(2), pp. 
398–405. doi: 10.1016/j.xphs.2015.11.041. 
Torp, R. et al. (1991) ‘Cellular and subcellular redistribution of glutamate-, glutamine- and 
taurine-like inmunoreactivities during forebrain ischemia: a semiquantitative electron 
microscopic study in rat hippocampus’, Neuroscience, 41(2/3), pp. 433–447. doi: 
10.1016/0306-4522(91)90339-P  
Tress, O. et al. (2012) ‘Panglial Gap Junctional Communication is Essential for Maintenance 
of Myelin in the CNS’, Journal of Neuroscience, 32(22), pp. 7499–7518. doi: 
10.1523/JNEUROSCI.0392-12.2012. 
Ueno, M. et al. (2013) ‘Layer v cortical neurons require microglial support for survival 
during postnatal development’, Nature Neuroscience. Nature Publishing Group, 16(5), pp. 
543–551. doi: 10.1038/nn.3358. 
Unger, V. M. et al. (1999) ‘Three-dimensional structure of a recombinant gap junction 
membrane channel.’, Science, 283(5405), pp. 1176–1180. doi: 
10.1126/science.283.5405.1176. 
Unterberg, A. W. et al. (2004) ‘Edema and brain trauma’, Neuroscience, 129, pp. 1021–1029. 
doi: 10.1016/j.neuroscience.2004.06.046. 
Watanabe, H. et al. (2002) ‘Heat-evoked activation of TRPV4 channels in a HEK293 cell 
expression system and in native mouse aorta endothelial cells’, Journal of Biological 
Chemistry, 277(49), pp. 47044–47051. doi: 10.1074/jbc.M208277200. 
Witthoft, A., Filosa, J. A. and Karniadakis, G. E. (2013) ‘Potassium buffering in the 
neurovascular unit: Models and sensitivity analysis’, Biophysical Journal. Biophysical 
Society, 105(9), pp. 2046–2054. doi: 10.1016/j.bpj.2013.09.012. 
 
 
69 
 
Woodruff, T. M. et al. (2011) ‘Pathophysiology, treatment, and animal and cellular models of 
human ischemic stroke’, Molecular Neurodegeneration. BioMed Central Ltd, 6(1), p. 11. doi: 
10.1186/1750-1326-6-11. 
Wu, L., Yu, X. and Feng, L. (2015) ‘Connexin 43 stabilizes astrocytes in a stroke-like milieu 
to facilitate neuronal recovery’, Acta Pharmacologica Sinica, (36), pp. 928–938. doi: 
10.1038/aps.2015.39. 
Xie, H. et al. (2017) ‘Evaluation of Connexin 43 Redistribution and Endocytosis in 
Astrocytes Subjected to Ischemia / Reperfusion or Oxygen-Glucose Deprivation and 
Reoxygenation’, BioMed research international. Hindawi, 2017, p. 5064683. doi: 
10.1155/2017/5064683. 
Yang, Y., Lewis, R. and Miller, R. H. (2011) ‘Interactions between oligodendrocyte 
precursors control the onset of CNS myelination’, Developmental Biology, 350(1), pp. 127–
138. doi: 10.1021/nn300902w.Release. 
Yao, X. et al. (2015) ‘Reduced brain edema and infarct volume in aquaporin-4 deficient mice 
after transient focal cerebral ischemia’, Neuroscience Letters, (584), pp. 368–372. doi: 
10.1016/j.neulet.2014.10.040.Reduced. 
Zamanian, J. L. J. et al. (2012) ‘Genomic Analysis of Reactive Astrogliosis’, The Journal of 
Neuroscience, 32(18), pp. 6391–6410. doi: 10.1523/JNEUROSCI.6221-11.2012.Genomic. 
Zhang, H. and Verkman, A. S. (2008) ‘Aquaporin-4 Independent Kir4.1 K+ Channel 
Function in Brain Glial Cells’, Molecular and Cellular Neuroscience, 37(1), pp. 1–10. doi: 
10.1016/j.mcn.2007.08.007. 
Zonta, M. et al. (2003) ‘Neuron-to-astrocyte signaling is central to the dynamic control of 
brain microcirculation’, Nature Neuroscience, 6(1), pp. 43–50. doi: 10.1038/nn980. 
 
